Power control of implantable device that supplies power by using ultrasonic wave

The implantable device uses ultrasound power control to achieve safe and consistent operation, overcoming the limitations of traditional batteries for smaller and deeper implantation.

JP2024156690AInactive Publication Date: 2024-11-06IOTA BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024111204
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-01-04
Filing Date
2024-07-10
Publication Date
2024-11-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing implantable medical devices face challenges in power supply due to the limitations of traditional batteries, which are large, toxic, and pose health risks, making it difficult to achieve smaller form factors and deeper implantation, while ultrasound power transmission can be unsafe if not properly controlled.

Method used

An implantable device powered by ultrasound, equipped with an ultrasound transducer and control circuit, adjusts power transmission based on feedback to ensure safe and consistent operation, using a power monitor and control circuit to regulate power consumption and supply.

Benefits of technology

Enables smaller, safer, and more deeply implantable devices by controlling ultrasound power to prevent overheating and ensure consistent operation, addressing health risks and feasibility issues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156690000001_ABST
    Figure 2024156690000001_ABST
Patent Text Reader

Abstract

To provide a method of controlling power to be supplied to an implantable device in a target by using ultrasonic waves and also to provide the implantable device.SOLUTION: A method includes: receiving powering supersonic waves having a wave power from an interrogator by an implantable device; converting energy from the powering supersonic waves into an electrical signal to provide power to the implantable device; and transmitting information indicating whether or not more power or less power should be transmitted to the implantable device to an interrogator.SELECTED DRAWING: Figure 3
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] [CROSS REFERENCE TO RELATED APPLICATIONS] This application claims the benefit of priority to U.S. Provisional Application No. 62 / 788,405, filed January 4, 2019, which is incorporated by reference herein for all purposes.

[0002] [Technical field] The present disclosure relates generally to implantable devices, and more particularly to implantable devices that are powered using ultrasound. [Background technology]

[0003] Invasive methods have been developed to treat various medical conditions in patients. These methods can include inserting an implantable medical device (IMD), such as a cardiac or neural bioimplant, into the patient's body. Powering such implantable devices remains a technical challenge for many biomedical applications. This is in part because traditional approaches using batteries, such as lithium batteries, to power implantable devices make the implantable devices too large to be safely and comfortably placed in many locations within the body, thereby limiting the feasibility of many biomedical applications. Furthermore, batteries typically generate power based on reactive chemicals, many of which are toxic and can pose health risks to the patient.

[0004] The disclosures of all publications, patents, and patent applications referenced herein are each incorporated herein by reference in their entirety. To the extent that any reference incorporated by reference conflicts with the present disclosure, the present disclosure shall control. Summary of the Invention

[0005] As discussed above, there is a need for implantable devices with smaller form factors (e.g., mm and sub-mm dimensions) to increase biocompatibility and reduce the invasiveness and discomfort caused by larger implantable devices that are powered, for example, using lithium batteries. In some embodiments, to achieve this smaller form factor, the implantable device may be configured to be powered using ultrasound waves that are receivable by one or more ultrasound transducers of the implantable device.

[0006] In some embodiments, using ultrasound to power implantable devices may be advantageous over other power approaches because biological tissue absorbs ultrasound at a significantly lower rate than other types of waves, such as radio frequency (RF) waves. This property of ultrasound not only reduces tissue heating due to energy absorbed by the tissue, but can also allow devices to be implanted deeper in a subject.

[0007] However, even with these advantages, ultrasound waves across biological tissues can still pose health risks if excessive power is transferred and causes dangerous temperature rises in exposed areas of the patient's body. On the other hand, many factors, such as implantation depth, orientation of the ultrasound transducer of the implantable device, or intervening biological material (e.g., ribs or organs) between the implantable device and the ultrasound source, can result in the energy received by the implantable device being insufficient or inconsistent to power its operation. Thus, there is a further need for systems, methods, and techniques that provide power control for ultrasonically powered implantable devices to enable safe operation and consistent power.

[0008] To address the above needs, in some embodiments, an implantable device in a subject includes an ultrasonic transducer configured to receive powering ultrasonic waves from an interrogator and convert the powering ultrasonic waves into electrical signals to power the implantable device, the ultrasonic transducer having a wave power, and a control circuit configured to generate information indicative of whether more or less power should be transmitted to the implantable device, the ultrasonic transducer further configured to transmit the information to the interrogator. As described further below, in some embodiments, the interrogator can be configured to receive the information and adjust the wave power of the transmitted powering ultrasonic waves based on the information so that the interrogator can provide sufficient power to the implantable device without incurring safety risks.

[0009] In some embodiments, the device includes a power monitor circuit configured to determine power available at the implantable device and to determine power consumed by the implantable device.

[0010] In some embodiments, the information includes a request for more or less power from the interrogator, hi some embodiments, the request is generated based on available power at the implantable device and power consumed by the implantable device.

[0011] In some embodiments, to transmit information, the ultrasonic transducer is configured to receive communication ultrasound from the interrogator and emit ultrasonic backscatter of the communication ultrasound, the backscattered communication ultrasound encoding information.

[0012] In some embodiments, to emit ultrasonic backscatter of the communication ultrasonic waves, the ultrasonic transducer is configured to generate an electrical signal based on the communication ultrasonic waves and modulate the generated electrical signal based on information to encode the information into the ultrasonic backscatter.

[0013] In some embodiments, the ultrasonic transducer is configured to receive a second powering ultrasonic wave from an interrogator configured to generate the second powering ultrasonic wave having a second wave power based on the information.

[0014] In some embodiments, the powering ultrasound comprises a pulse width modulated (PWM) signal. In some embodiments, the interrogator is configured to adjust an instantaneous intensity value or a pulse width of the PWM signal based on the information. In some embodiments, the interrogator is configured to adjust an instantaneous intensity value and a pulse width of the PWM signal based on the information.

[0015] In some embodiments, the apparatus includes a voltage sensor configured to determine a maximum voltage of the ultrasonic transducer, and the power monitor circuit is configured to determine the available power based on the maximum voltage.

[0016] In some embodiments, the apparatus includes a power conveyor circuit configured to charge the energy storage device based on the electrical signal, and the power monitor circuit is configured to determine the available power based on the energy storage device energy, hi some embodiments, the power monitor circuit is configured to determine the available power based on a rate of change of energy stored in the energy storage device.

[0017] In some embodiments, the electrical signal generates a first voltage, the control circuit is configured to control one or more switches to control a plurality of capacitors configured to convert the first voltage to a second voltage to power the implantable device, and the power monitor circuit is configured to determine the available power based on a switching frequency of at least one of the one or more switches.

[0018] In some embodiments, the power monitor circuit is configured to determine the power consumption of the implantable device based on an operational mode of the implantable device. In some embodiments, the operational mode includes neural stimulation, neural activity recording, or measuring or detecting a physiological condition. In some embodiments, the physiological condition includes temperature, pH, pressure, heart rate, strain, oxygen partial pressure, the presence of an analyte, or the amount of an analyte.

[0019] In some embodiments, the consumed power is consumed by a load circuit of the implantable device, and the power monitor circuit is configured to detect a current value of a current driving the load circuit and determine the power consumption based on the detected current value. In some embodiments, the load circuit is configured to execute an operating mode.

[0020] In some embodiments, the power monitor circuit is configured to determine a supplied power provided by the electrical signal, the electrical signal generating a first voltage at a first node. In some embodiments, the control circuit is configured to determine whether the supplied power is greater than the consumed power. In some embodiments, the apparatus includes a power conveyor circuit configured to receive the first voltage at a first voltage node and convert the first voltage to a second voltage to power the implantable device based on the electrical signal, the consumed power being related to the second voltage.

[0021] In some embodiments, the apparatus includes a voltage sensor configured to determine a maximum voltage of the ultrasonic transducer, and the power monitor circuit is configured to determine the supplied power based on the maximum voltage.

[0022] In some embodiments, the control circuit is configured, in response to determining that the supply power exceeds the power consumption, to control the power conveyor circuit to charge an energy storage device based on a first voltage node, where charging the energy storage device reduces the first voltage.

[0023] In some embodiments, the control circuitry is configured to determine whether the energy storage device is fully charged.

[0024] In some embodiments, the control circuitry is configured to, in response to determining that the power supply exceeds the power consumption and that the energy storage device is fully charged, control the ultrasonic transducer to transmit information to the interrogator including an indication that the implantable device is powered by excess power. In some embodiments, the information including the indication is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power that is less than the wave power of the powering ultrasonic wave.

[0025] In some embodiments, the control circuit is configured to determine whether the first voltage exceeds a predetermined voltage level, and in response to determining that the first voltage exceeds the predetermined voltage level and the energy storage device is fully charged, opens one or more switches configured to generate an electrical signal from the powering ultrasound to reduce the supplied power.

[0026] In some embodiments, the control circuit is configured, in response to determining that the supplied power is less than the consumed power, to control the power conveyor circuit to discharge the energy storage device via the first voltage node, such that by discharging the energy storage device, the first voltage is increased.

[0027] In some embodiments, the control circuitry is configured, in response to determining that the supplied power is less than the consumed power, to control the ultrasonic transducer to transmit information to the interrogator including an indication that the implantable device is underpowered. In some embodiments, the information including the indication is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power greater than the wave power of the powering ultrasonic wave.

[0028] In some embodiments, the interrogator device includes an ultrasonic transducer configured to transmit a first powering ultrasonic wave to the implantable device, where the first powering ultrasonic wave transmits an ultrasonic wave having a first wave power to the implantable device; an ultrasonic transducer configured to receive a communication ultrasonic wave from the implantable device, where the communication ultrasonic wave includes information indicating whether more power or less power should be transmitted to the implantable device; and an ultrasonic transducer configured to transmit a second powering ultrasonic wave to the implantable device, where the second powering ultrasonic wave is a second wave power based on the information.

[0029] In some embodiments, the interrogator device includes a controller configured to extract information from the communication ultrasound and to control the ultrasound transducer to transmit a second powering ultrasound having a second power.

[0030] In some embodiments, the communication ultrasound includes ultrasonic backscatter of a previously transmitted communication ultrasound.

[0031] In some embodiments, the second power supply ultrasonic wave includes a PWM signal. In some embodiments, the ultrasonic transducer is configured to control the instantaneous intensity value or pulse width of the PWM signal based on the information to make the second power supply ultrasonic wave have a second wave power.

[0032] In some embodiments, a method for controlling power provided to an implantable device in a subject is implemented in the implantable device and includes the steps of receiving a powering ultrasound wave from an interrogator, the powering ultrasound wave having wave power, converting energy from the powering ultrasound wave into an electrical signal to power the implantable device, and transmitting information to the interrogator indicating whether more or less power should be transmitted to the implantable device.

[0033] Further described herein are various method embodiments for controlling power provided by an interrogator to an implantable device according to any of the previously described embodiments.

[0034] The foregoing summary, as well as the following detailed description of the embodiments, will be better understood when read in conjunction with the accompanying drawings, in which: For the purpose of illustrating the disclosure, the drawings show exemplary embodiments of the disclosure, but the disclosure is not limited to the specific methods and instrumentalities disclosed. [Brief description of the drawings]

[0035] [Figure 1] 1 illustrates a system including an implantable device that is powered using ultrasound, according to some embodiments.

[0036] [Diagram 2] 1 illustrates a system including an interrogator configured to power one or more implantable devices using ultrasound, according to some embodiments.

[0037] [Diagram 3] 1 illustrates a method for controlling power provided by an interrogator to an implantable device, according to some embodiments.

[0038] [Figure 4] 1 illustrates a method for determining information indicative of whether more or less power should be transmitted from an interrogator to an implantable device, according to some embodiments.

[0039] [Diagram 5] 1 shows a diagram of an implantable device configured to interact with a nerve of a subject, according to some embodiments. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0040] Described herein are systems and methods for controlling power provided to a device implanted in a subject and powered using ultrasound. As described above, these power controls may allow the implantable device to operate safely and provide consistent power. Thus, an implantable device powered using ultrasound may retain the advantages offered by ultrasound, such as allowing for smaller form factors and greater implantable depths, without the potential drawbacks associated with the use of ultrasound. In some embodiments, such an implantable device includes an ultrasound transducer configured to receive a powering ultrasound having a wave power from an interrogator and convert the powering ultrasound into an electrical signal to power the implantable device. The implantable device may include a control circuit configured to generate information indicative of whether more or less power should be transmitted to the implantable device. In some embodiments, the ultrasound transducer may be further configured to transmit the information to the interrogator. In some embodiments, the interrogator may be configured to receive the information and adjust the wave power of the transmitted powering ultrasound based on the information.

[0041] FIG. 1 illustrates a system 100 including an implantable device 104 powered using ultrasound, according to some embodiments. In some embodiments, the implantable device 104 may be wirelessly powered by ultrasound transmitted from the interrogator 102, as described further below with respect to FIG. 2. In some embodiments, the implantable device 104 may be configured to wirelessly communicate with the interrogator 102 via ultrasound communication. In some embodiments, the implantable device 104 may be implanted within a subject, such as a patient, and the interrogator 102 may be a separate device that is external to the subject (i.e., not implanted) or fully implanted within the subject. In some embodiments, the power provided by the interrogator 102 may be controlled based on bidirectional communication between the interrogator 102 and the implantable device 104. In some embodiments, the interrogator 102 and the implantable device 104 may be configured to communicate with each other using ultrasound.

[0042] In some embodiments, to enable the implantable device 104 to be powered using ultrasound, the implantable device 104 may include the following device components: ultrasonic transducer circuitry 106, modulation / demodulation circuitry 112, stimulation circuitry 114, detection circuitry 116, control circuitry 120, and power circuitry 130. In some embodiments, one or more of these device components may be implemented as digital circuits, analog circuits, or mixed-signal integrated circuits, depending on their operation. For example, the control circuitry 120 may include a microprocessor, a finite state machine, a field programmable gate array, or a microcontroller.

[0043] In some embodiments, the ultrasonic transducer circuit 106 includes an ultrasonic transducer 108 coupled to a matching network 110. In some embodiments, the ultrasonic transducer circuit 106 does not include a matching network 110. In some embodiments, the ultrasonic transducer 108 can be configured to receive ultrasonic waves from the interrogator 102 and convert energy from the received ultrasonic waves into an electrical signal to power one or more device components of the implantable device 104. In some embodiments, the electrical signal can be generated by the ultrasonic transducer 108 because vibrations of the ultrasonic transducer 108 caused by the received ultrasonic waves induce a voltage across electrical terminals of the ultrasonic transducer 108, causing a current to flow.

[0044] In some embodiments, as described above, power from received ultrasound waves can be used by the implantable device 104 to power its device components. Thus, these ultrasound waves may be referred to herein as powering ultrasound waves. In some embodiments, the received ultrasound waves can encode information including instructions for operating the implantable device, and thus, these ultrasound waves may be referred to herein as communication ultrasound waves. Similar to how the powering ultrasound waves are processed in some embodiments, the communication ultrasound waves can be received by the ultrasonic transducer 108 and generate an electrical signal having a current flowing through the ultrasonic transducer 108. In some embodiments, the generated electrical signal encodes information in the current. In some embodiments, the same ultrasound waves can be configured to both power the implantable device 104 and encode information for transmission to the implantable device 104.

[0045] In some embodiments, the ultrasonic transducer circuit 106 includes multiple ultrasonic transducers coupled to multiple corresponding matching networks. According to some embodiments, by including at least two ultrasonic transducers, the implantable device 104 may be configured to be powered by electrical signals generated by the at least two ultrasonic transducers to more efficiently and consistently extract the power provided by the interrogator 102.

[0046] For example, as discussed above, many factors, such as the orientation of the ultrasonic transducer or intervening biological material between the ultrasonic transducer 108 and the ultrasonic source interrogator 102, can significantly reduce the power that can be received at the ultrasonic transducer 108. By adding one or more additional ultrasonic transducers, a reduction in the power that can be received at a single ultrasonic transducer (e.g., the ultrasonic transducer 108) may be less likely to adversely affect the operation of the implantable device 104. In some embodiments, one or more of these ultrasonic transducers may be micromachined ultrasonic transducers, such as capacitive micromachined ultrasonic transducers (CMUTs) or piezoelectric micromachined ultrasonic transducers (PMUTs), or may be bulk piezoelectric transducers. Further implementations of the ultrasonic transducer 108 are described below with respect to FIG. 5.

[0047] In some embodiments, the matching network 110 may be an electronic circuit configured to select an impedance match between the electrical impedance of the ultrasonic transducer 108 and the electrical impedance of the implantable device 104 (e.g., the power circuit 130) to reduce signal reflections. In some embodiments, the matching network 110 may be realized with various configurations of one or more circuit elements, such as inductors, capacitors, resistors, diodes, transistors, or any combination thereof. For example, the matching network 110 may be implemented as multiple capacitors connected in parallel and coupled to multiple corresponding switches. By controlling which switches are opened or closed, the matching network 110 can control how the multiple capacitors are charged to select the impedance. In some embodiments, the matching network 110 can be configured to allow the electrical signal generated by the ultrasonic transducer 108 to bypass the multiple capacitors through separate wires controlled by the switches.

[0048] In some embodiments, the power circuit 130 can include a power recovery circuit 132 electrically coupled to the conditioning circuit 138 to enable powering the implantable device 104 using ultrasound. In some embodiments, the power recovery circuit 132 can be configured to receive and process the electrical signal generated by the ultrasound transducer circuit 106. In some embodiments, the power recovery circuit 132 can include a rectifier circuit (e.g., an active rectifier element) for converting the electrical signal in an AC form to a DC form, and the converted electrical signal can be related to a first voltage (i.e., a supply voltage of the received ultrasound).

[0049] In some embodiments, due to health risks in propagating high power waves through the biological tissue of a subject, government regulations may limit the amount of power provided by the ultrasound transmitted by the interrogator 102 (e.g., 720 mW / cm 2) may be limited. Thus, the first voltage derived from the received ultrasound may not be high enough to operate the electronic components of the implantable device 104. For example, transistors used in complementary metal oxide semiconductor (CMOS) technology may require a minimum of about 2 volts to operate the transistor.

[0050] In some embodiments, the powering ultrasound may be transmitted as a pulse width modulated (PWM) signal to provide a higher first voltage to operate the implantable device 102 of the electronic component. In some embodiments, by transmitting the powering ultrasound as a PWM signal, the interrogator 102 may be configured to provide short, high intensity pulses such that the average intensity remains within regulation limits and to provide higher instantaneous power to generate the higher first voltage. In some embodiments, the interrogator may be configured to control the instantaneous intensity and / or pulse width of the PWM signal (e.g., example ultrasound settings) to control the power provided by the powering ultrasound.

[0051] In some embodiments, to enable the implantable device 104 to be powered by these ultrasound waves, the power conveyor circuit 134 can include a charge pump configured to convert a first voltage to a second voltage greater than the first voltage. In some embodiments, the charge pump can include a plurality of connected capacitors controlled by one or more switches to generate the second voltage. In some embodiments, the charge pump can achieve a conversion gain of at least 1x, 2x, 3x, or 4x. In some embodiments, the magnitude of the second voltage can be controlled based on a switching frequency of one or more switches.

[0052] As discussed above, the power provided by the received ultrasound may be inconsistent due to many factors including, for example, the implantation depth of the implantable device 104 or the intervening biological material between the ultrasound transducer 108 and the ultrasound source, e.g., the interrogator 102. Thus, in some embodiments, to provide more consistent power to the implantable device 104, the power recovery circuit 132 may include an energy storage device 136 coupled to the power conveyor circuit 134. In some embodiments, the energy storage device may include a battery or a storage capacitor. In some embodiments, the energy storage device may be configured as a storage capacitor to maintain a small form factor of the implantable device 104.

[0053] In some embodiments, the storage capacitor can have a capacitance that is at least 0.1 μF, at least 0.25 μF, at least 0.5 μF, at least 1 μF, at least 2 μF, at least 4 μF, or at least 8. In some embodiments, the storage capacitor can have a capacitance less than 10 μF, less than 8 μF, less than 4 μF, less than 2 μF, less than 1 μF, less than 0.5 μF, or less than 0.25 μF. For example, the storage capacitor can have a capacitance in the range of 0.1 to 10 μF, such as in the range of 0.5 to 2 μF. In some embodiments, the storage capacitor can have a capacitance that is about 1 μF.

[0054] In some embodiments, the implantable device 104 may be configured to operate in at least two power modes to allow the energy storage device 136 to more efficiently utilize the ultrasonic power received by the implantable device 104 and provide more consistent power. In some embodiments, the power modes include a charge mode in which a portion of the ultrasonic power received by the energy storage device 136 may be conveyed to the energy storage device 136, which may store the energy. In some embodiments, the power conveyor circuit 134 may be configured to charge the energy storage device 136 based on the generated first voltage. In some embodiments, the power modes include a discharge mode in which a portion of the energy stored in the energy storage device 136 is discharged to convey power from the energy storage device 136 and provide additional power to other device components of the implantable device 104 (e.g., the stimulation circuit 114, the detection circuit 116, or the control circuit 120, etc.). In some embodiments, the power flow to and from the energy storage device 136 may be sent via the power conveyor circuit 134.

[0055] In some embodiments, the conditioning circuit 138 may be configured to regulate the output voltage (e.g., the second voltage) generated by the power conveyor circuit 134 and supply the regulated voltage to one or more circuit loads of the implantable device 104. In some embodiments in which the power conveyor circuit 134 includes a charge pump, the conditioning circuit 138 may be configured to remove or reduce potential voltage ripple caused by an operating switch of the charge pump. In some embodiments, the conditioning circuit 138 includes a DC voltage regulator (e.g., a low dropout (LDO) regulator) to regulate the voltage supplied to the digital circuit loads of the implantable device 104. In some embodiments, the conditioning circuit 138 includes a DC voltage regulator (e.g., a low dropout (LDO) regulator) to regulate the voltage supplied to the digital circuit loads of the implantable device 104. In some embodiments, the conditioning circuit 138 includes an AC voltage regulator (e.g., a low dropout (LDO) regulator) to regulate the voltage supplied to the analog circuit loads of the implantable device 104.

[0056] In some embodiments, the modulation / demodulation circuitry 112 may include demodulation circuitry configured to demodulate electrical signals generated by the ultrasonic transducer circuitry 106 to extract information encoded in the received ultrasonic waves. In some embodiments, the demodulation circuitry may transmit the extracted information, including instructions, to control circuitry 120 configured to control how the implantable device 104 operates based on the instructions.

[0057] In some embodiments, the modulation / demodulation circuitry 112 may include modulation circuitry configured to encode information using ultrasonic backscatter to enable the implantable device 104 to wirelessly communicate information with the interrogator 102. This information is generated by the implantable device 104 and, for ease of explanation, may be referred to as device information in the following description.

[0058] Generally, when the implantable device 104 is implanted within a subject, ultrasound waves (including a carrier wave) emitted by the ultrasound transceiver of the interrogator 102 pass through biological tissue before being received by the ultrasound transducer circuitry 106 of the implantable device 104. As described above, the carrier wave induces mechanical vibrations on the ultrasound transducer 108 (e.g., a bulk piezoelectric transducer) generating a voltage across the ultrasound transducer 108, which then drives a current through the remainder of the implantable device 104. In some embodiments, the current through the ultrasound transducer 108 causes the ultrasound transducer circuitry 106 to emit backscattered ultrasound waves that correspond to the received ultrasound waves.

[0059] In some embodiments, the modulation circuitry can be configured to modulate the current through the ultrasonic transducer 108 to encode device information, such that the resulting ultrasonic backscatter waves also encode device information. Thus, ultrasonic backscatter emitted from the implantable device 104 can encode device information associated with the implantable device 104. In some embodiments, the modulation circuitry can include one or more switches, such as an on / off switch or a field effect transistor (FET). An example FET that may be used with some embodiments of the implantable device 104 includes a metal-oxide-semiconductor field effect transistor (MOSFET). In some embodiments, the modulation circuitry can be configured to change the impedance of the current through the ultrasonic transducer 108, such that the variation in the current that flows encodes information.

[0060] 2 and 3, according to some embodiments, the ultrasonic backscatter may be received and decoded by the interrogator 102 to extract device information encoded in the ultrasonic backscatter. In some embodiments, the ultrasonic backscatter may be received by an interrogator that may be the same or different from the interrogator 102 that transmitted the ultrasonic waves received by the ultrasonic transducer 108.

[0061] In some embodiments, the detection circuitry 116 can be configured to communicate with one or more sensors 140A-C to measure or detect one or more physiological conditions of a subject. In some embodiments, the detection circuitry 116 can include drivers configured to provide current to the one or more sensors 140A-C and receive signals generated from the one or more sensors 140A-C. In some embodiments, the received signals can include information representative of the detected physiological condition or information representative of the measured physiological condition. In some embodiments, the detection circuitry 116 can be configured to transmit information to the control circuitry 120.

[0062] In some embodiments, one or more of the sensors 140A-C may be disposed internal to the implantable device 104 or may be coupled to the exterior of the implantable device 104. In some embodiments, the implantable device 104 includes at least two sensors 140A-C. In some embodiments, the one or more physiological conditions may include temperature, pH, pressure, heart rate, strain, oxygen pressure, the presence of an analyte, or an amount of an analyte. For example, the analyte may be oxygen or glucose.

[0063] In some embodiments, the sensors 140A-C can include optical sensors. In some embodiments, the optical sensors include a light source and a light detector. In some embodiments, the optical sensors detect blood pressure or pulse. In some embodiments, the optical sensors include a matrix including fluorophores or luminescent probes, where the fluorescence intensity or fluorescence lifetime of the fluorophores depends on the amount of analyte. In some embodiments, the optical sensors are configured to perform near infrared spectroscopy. In some embodiments, the optical sensors detect glucose.

[0064] In some embodiments, the sensors 140A-C may include potentiometric or amperometric chemical sensors, hi some embodiments, the sensors detect oxygen, pH, or glucose.

[0065] In some embodiments, the sensors 140A-C may include a temperature sensor, hi some embodiments, the temperature sensor is a thermistor, a thermocouple, or a proportional to absolute temperature (PTAT) circuit.

[0066] In some embodiments, the sensors 140A-C may include pressure sensors. In some embodiments, the pressure sensors are Micro-Electro-Mechanical Systems (MEMS) sensors. In some embodiments, the detection circuit 116 is configured to measure blood pressure or pulse.

[0067] In some embodiments, the sensors 140A-C may include strain sensors.

[0068] In some embodiments, the detection circuit 116 may be configured to, for example, communicate with the sensor 140C to detect electrophysiological signals from a nerve or a targeted subset of nerve fibers within the nerve, as further described below with respect to FIG. 5. In some embodiments, the sensor 140C may include electrode pads that may be the same as or different from the electrode pads 142 operated by the stimulation circuit 114. In some embodiments, the detection circuit 116 may be configured to record neural activity of the nerve or the targeted subset of nerve fibers based on the detected electrophysiological signals.

[0069] In some embodiments, one or more techniques such as computational modeling (e.g., finite element models), inverse source estimation, multipolar (e.g., tripolar) neural recording, velocity selective recording, or beamforming can be implemented by the detection circuitry 116 (alone or in conjunction with the control circuitry 120) to selectively target a subset of nerve fibers. See, for example, Taylor et al., Multiple-electrode nerve cuffs for low-velocity and velocity selective neural recording, Medical & Biological Engineering & Computing, vol. 42, pp. 634643 (2004) and Wodlinger et al., Localization and Recovery of Peripheral Neural Sources with Beamforming Algorithms, IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 17, no. 5, pp. 461-468 (2009).

[0070] In some embodiments, the detection circuit 116 can be configured to operate multiple electrodes of the sensor 140C for targeted detection of electrophysiological signals. For example, the sensor 140C can be a curved member extending from the implantable device 104, as further described below with respect to FIG. 5. In some embodiments, the detection circuit 116 can analyze the electrophysiological signals detected by all or a subset of the electrode pads to determine a subset of nerve fibers in the nerve that are transmitting the electrophysiological signal. A particular nerve may transmit a compound electrophysiological signal (or compound action potential), which is the sum of electrophysiological signals (or action potentials) transmitted simultaneously by two or more different subsets of nerve fibers. Based on the electrophysiological signals detected by the multiple electrode pads, the detection circuit 116 can determine which subset of nerve fibers transmit which electrophysiological signal. In some embodiments, data received from the interrogator 102 (such as temperature data, or data related to analyte concentration or other physiological condition) is further used to determine which subset of nerve fibers transmit the electrophysiological signal.

[0071] For example, in some embodiments, the detection circuitry 116 may be configured to selectively detect electrophysiological signals from a targeted subset of nerve fibers using rate-selective recording, which may be combined with multipolar (e.g., tripolar) recording (which may include any number of tripolar electrodes within multiple electrodes on one or more curved members).

[0072] Beamforming may additionally or alternatively be used to detect electrophysiological signals from a targeted subset of nerve fibers. Some or all of the electrode pads of the one or more curved members may detect electrophysiological signals from the nerve, and the detection circuit 116 may determine a cross-sectional location of the transmitted signal within the nerve based on differences in the electrophysiological signals detected by some or all of the electrode pads of the one or more curved members.

[0073] In some embodiments, stimulation of one or more nerves at a location remote from the location of the implantable device 104 can result in modulation of electrophysiological signals at the location of the implantable device 104. Modulation of electrophysiological signals detected at different subsets of nerve fibers in a nerve in electrical communication with an electrode pad (e.g., electrode pad 142) of the implantable device 104 can be the result of stimulation at different remote nerves. For example, stimulation of the splenic nerve can result in modulation of electrophysiological signals detected from a first subset of nerve fibers in the vagus nerve, and stimulation of the renal nerve can result in modulation of electrophysiological signals detected from a second subset of nerve fibers in the vagus nerve. Thus, an implantable device positioned on the vagus nerve can detect electrophysiological signals from a first subset of nerve fibers to monitor stimulation of the splenic nerve and a second subset of nerve fibers to monitor stimulation of the renal nerve.

[0074] In some embodiments, the stimulation circuit 114 can be configured to deliver targeted electrical pulses to a subset of nerve fibers in the nerve by selectively activating one or more electrode pads 142 connected to the subset of nerve fibers. In some embodiments, the implantable device 104 can include one or more curved members that electrically connect the stimulation circuit 114 to the electrode pads 142, as further described below with respect to FIG.

[0075] In some embodiments, the stimulation circuitry 114 may be controlled by the control circuitry 120 to operate or selectively activate the electrode pads 142. Selective activation may include, for example, activating a portion of the electrode pads in the plurality of electrode pads 142 of one or more curved members and / or differentially activating all or a portion of the electrode pads in the plurality of electrode pads 142 of one or more curved members. Thus, the plurality of electrodes may be manipulated to direct electrical pulses emitted by the plurality of electrode pads 142 to a targeted subset of nerve fibers. According to some embodiments, techniques such as electric field interference or multipolar stimulation (e.g., tripolar stimulation) may be used to target electrical pulses to a subset of nerve fibers in a nerve. See, e.g., Grossman, et al., Noninvasive Deep Brain Stimulation via Temporally Interfering Electrical Fields, Cell, vol. 169, pp. 1029-1041 (2017). Electrode pads 142 within one or more of the curved members can be selectively activated by the control circuitry 120 to target the emitted electrical pulses to a subset of nerve fibers.

[0076] The subset of nerve fibers targeted by the emitted electrical pulse may be the same or different from the subset of nerve fibers for which electrophysiological signals are detected by the detection circuit 116. The one or more curved members configured to emit the targeted electrical pulse may be the same or different from the one or more curved members on the implantable device 104 configured to detect the electrophysiological signals. The emitted targeted electrical pulse may stimulate a nerve at the location of the implantable device 104. The subset of nerve fibers targeted by the electrical pulse may be the same or a different subset of nerve fibers for which electrophysiological signals are selectively detected.

[0077] The subset of nerve fibers targeted by the electrical pulses emitted by the implantable device 104 can be, for example, one or more (e.g., 2, 3, 4, or more) fiber bundles, or a portion of one or more (e.g., 2, 3, 4, or more) fiber bundles in a nerve. In some embodiments, the subset of nerve fibers includes or consists of the afferent nerve fibers in the nerve, or a subset of the afferent nerve fibers in the nerve. In some embodiments, the subset of nerve fibers includes or consists of the efferent nerve fibers in the nerve, or a subset of the efferent nerve fibers in the nerve. In some embodiments, the subset of nerve fibers includes or consists of the efferent nerve fibers in two or more fiber bundles in the nerve, or the afferent nerve fibers in two or more fiber bundles in the nerve.

[0078] Targeted stimulation of a subset of nerve fibers by releasing a targeted electrical pulse to the subset of nerve fibers may result in stimulation of a nerve at a location remote from the location of the nerve. The remote nerve stimulated by the implantable device 104 depends on the subset of nerves at the location of the implantable device 104 that are targeted by the electrical pulse released by the device. In some embodiments, the implantable device 104 is placed at a first nerve location and configured to stimulate a second nerve location by releasing a targeted electrical pulse to a subset of nerve fibers in the first nerve location that is associated with the second nerve location. In some embodiments, the first nerve location and the second nerve location are separated by one or more nerve branch points or one or more synapses. In some embodiments, the second nerve location is proximal to the brain relative to the first nerve location, and in some embodiments, the second nerve location is distal to the brain relative to the first nerve location. In some embodiments, the targeted subset of nerve fibers includes or consists of afferent nerve fibers. In some embodiments, the targeted subset of nerve fibers comprises or consists of efferent nerve fibers.

[0079] In some embodiments, control circuitry 120 includes a command processor 122, a power monitor 124, and a memory 126. In some embodiments, memory 126 includes non-transitory storage memory, such as a register memory, a processor cache, or a random access memory (RAM). In some embodiments, control circuitry 120 may be a digital circuit, an analog circuit, or a mixed-signal integrated circuit. Examples of control circuitry 120 may include a microprocessor, a finite state machine, a field programmable gate array, and a microcontroller.

[0080] In some embodiments, the command processor 122 may be configured to receive instructions from information encoded in the received ultrasound and extracted by the modulation / demodulation circuitry 112. In an embodiment, the instructions received by the command processor 122 may be stored in the memory 126, such as an instruction register. In some embodiments, the command processor 122 may be configured to control the implantable device 104 to enter an operational mode based on the instructions and stored logic. For example, the command processor 122 may be implemented as an FSM that controls the operational mode of the implantable device 104 based on a current operational mode and one or more detected inputs, such as one or more received instructions, one or more sensor values, or a combination thereof.

[0081] Information encoded in the ultrasound emitted by the interrogator and received by the closed-loop implantable device may include, for example, instructions to start or stop neuromodulation, one or more calibration instructions, one or more updates to the operating software, and / or one or more templates (such as a template electrophysiological signal, one or more template electrophysiological signals, and / or one or more template stimulation signals). In an embodiment, the command processor 122 may be configured to process and store the received instructions in the memory 126. In some embodiments, the command processor 122 may enter an operating mode from a plurality of operating modes based on the received one or more instructions. In some embodiments, the plurality of operating modes may include a mode for stimulating a nerve, a mode for recording neural activity, or a mode for determining one or more physiological conditions. For example, if the instruction indicates that the implantable device 104 should enter a neural stimulation mode, the control circuitry 120 may be configured to control the stimulation circuitry 114 to stimulate a particular nerve fiber or portion of a nerve.

[0082] In some embodiments, when command processor 122 controls implantable device 104 to enter a neural activity recording mode or modes to determine one or more physiological conditions, command processor 122 may control detection circuitry 116 to retrieve device information (e.g., neural recording or detected / measured physiological conditions). In some embodiments, upon retrieving the device information, command processor 122 may be configured to control modulation / demodulation circuitry 112 to encode the device information in the ultrasound backscatter, as described above.

[0083] In some embodiments, to provide power control to the implantable device 104, the power monitor 124 may be configured to monitor the available power and power consumption of the implantable device 104, as described further below with respect to FIG. 3. In some embodiments, the available power may include a supply power provided by ultrasound received at the ultrasonic transducer 108 and may include accessible power stored in the implantable device 104. For example, the accessible power may include power accessible from an energy storage device 136 that accumulates excess energy. In some embodiments, the power monitor 124 may determine the power consumption based on an output voltage generated by the power conveyor circuit 134, as described further below with respect to FIG.

[0084] In some embodiments, command processor 122 may be configured to generate information indicating whether more or less power should be sent to implantable device 104 based on available power and power consumption monitored by power monitor 124. In some embodiments, control circuitry 120 may be configured to implement method 400, as described further below with respect to FIG 4, to generate the information. In some embodiments, control circuitry 120 may be configured to control modulation / demodulation circuitry 112 to encode the generated information with ultrasonic backscatter, as described further below with respect to FIG 3.

[0085] 2 illustrates a system 200 including an interrogator 202 configured to power one or more implantable devices 240 using ultrasound, according to some embodiments. In some embodiments, the interrogator 202 may be an example of the interrogator 102 or the interrogator 302 as described with respect to Figures 1 and 3, respectively. In some embodiments, the interrogator 202 may be configured to perform one or more of the steps of the method 400 of Figure 4, as described below.

[0086] In some embodiments, the interrogator 202 includes a power supply 203, a computation circuit 210, a signal generation circuit 220, and an ultrasonic transducer circuit 204. As shown, the power supply 203 can be configured to provide power to the computation circuit 210 and the signal generation circuit 220. In some embodiments, the power supply 203 can provide 1.8V, although any suitable voltage can be used. For example, the power supply 203 can include one or more batteries to provide the 1.8V.

[0087] In some embodiments, the signal generation circuit 220 includes a charge pump 222 configured to power one or more channels 224. In some embodiments, the charge pump 222 can be configured to increase the voltage provided by the power supply 203. For example, the charge pump 222 may increase the 1.8V provided by the power supply 203 to 32V.

[0088] In some embodiments, each channel 224 is coupled to and controls the operation of a corresponding ultrasonic transducer 208 of the transducer circuitry 204. In some embodiments, an ultrasonic transducer 208 connected to a channel 224 may be configured to only receive ultrasonic waves or only transmit ultrasonic waves, in which case the switch 229 may optionally be omitted from the channel 224. In some embodiments, each channel 224 may include a delay control 226, a level shifter 228, and a switch 229.

[0089] In some embodiments, the delay control 226 can be configured to control the ultrasonic waveform and / or signal transmitted by the ultrasonic transducer 208. In some embodiments, the delay control 226 can control, for example, the phase shift, time delay, pulse frequency, waveform (including amplitude and wavelength), or combinations thereof, based on commands from the control circuitry 212 to generate the transmit waveform. In some embodiments, data representing the waveform and frequency of each channel can be stored in the delay control 226 or in a "wave table" stored in the memory 216. This allows the transmit waveform on each channel 224 to be different.

[0090] In some embodiments, the delay control 226 can be connected to a level shifter configured to shift the input pulse from the delay control 226 to a higher voltage that the ultrasonic transducer 208 uses to transmit ultrasonic waves. In some embodiments, the delay control 226 and level shifter 228 can be configured to be used to stream data into the actual transmit signal to the transducer array 206. In some embodiments, the transmit waveform for each channel 224 can be generated directly by a high speed serial output of a microcontroller or other digital system and sent to the transducer elements (e.g., ultrasonic transducer 208) via the level shifter 228 or high voltage amplifiers.

[0091] In some embodiments, a switch 229 of a channel 224 can configure a corresponding ultrasound transducer 208 to receive ultrasound waves, such as ultrasound backscatter. In some embodiments, the received ultrasound waves are converted to electrical current by the ultrasound transducer 208 (set in receive mode) and sent to a data processor 211 for processing data captured with the received ultrasound. In some embodiments, the received ultrasound waves can be processed by including an amplifier, an analog-to-digital converter (ADC), a variable gain amplifier, or a time-gain controlled variable gain amplifier that compensates for tissue loss, and / or a bandpass filter.

[0092] In some embodiments, the aforementioned channels 224 do not include a T / Rx switch 229, but instead include separate Tx (transmit) and Rx (receive) circuits with a high voltage Rx (receive circuit) in the form of a low noise amplifier with good saturation recovery. In some embodiments, the T / Rx circuit includes a circulator. In some embodiments, the transducer array 206 includes more transducer elements (e.g., ultrasonic transducers 208) than the processing channels 224, and the interrogator 202 can be configured to include a multiplexer to select a different set of transmit elements for each pulse. For example, 64 transmit / receive channels can be connected to 192 physical transducer elements via a 3:1 multiplexer, with only 64 transducer elements being active on a given pulse.

[0093] In some embodiments, the computation circuitry 210 may be a digital circuit, an analog circuit, or a mixed signal integrated circuit. Examples of the computation circuitry 210 may include a microprocessor, a finite state machine, a field programmable gate array, and a microcontroller. In some embodiments, the interrogator 202 may include non-volatile memory, which may be accessed by the computation circuitry 210.

[0094] In some embodiments, the computation circuit 210 includes a control circuit 212 and a data processor 211. In some embodiments, the control circuit 212 includes a command generator 214 and a memory 216 that stores ultrasound settings 218.

[0095] In some embodiments, the command generator 214 may be configured to generate instructions to control the operation of the delay control 226. In some embodiments, based on device information received from an implantable device, such as the implantable device 242, the command generator 214 may be configured to set or select an ultrasound setting to control the output power of the transmitted ultrasound, as described further below with respect to FIG. 3. For example, the received device information may indicate that more power should be transmitted to the implantable device 242. In this example, the command generator 214 may select an ultrasound setting 218, such as a higher pulse width or higher instantaneous intensity of the waveform, to increase the power of the ultrasound transmitted by the ultrasound transducer circuitry 204.

[0096] In some embodiments, the transducer circuit 204 includes one or more ultrasound transducers 208 configured to transmit ultrasound waves to an implantable device 240, such as implantable device 242. In some embodiments, as shown in Figure 2, the transducer circuit 204 includes a transducer array 206 having a plurality of ultrasound transducers 208. In some embodiments, the transducer array 206 includes 1 or more, 2 or more, 3 or more, 5 or more, 7 or more, 10 or more, 15 or more, 20 or more, 25 or more, 50 or more, 100 or more, 250 or more, 500 or more, 1000 or more, 2500 or more, 5000 or more, or 10,000 or more ultrasound transducers. In some embodiments, the transducer array 206 includes 100,000 or less, 50,000 or less, 25,000 or less, 10,000 or less, 5000 or less, 2500 or less, 1000 or less, 500 or less, 200 or less, 150 or less, 100 or less, 90 or less, 80 or less, 70 or less, 60 or less, 50 or less, 40 or less, 30 or less, 25 or less, 20 or less, 15 or less, 10 or less, 7 or less, or 5 or less ultrasonic transducers. The transducer array 206 may be, for example, a chip with 50 or more ultrasonic transducer pixels.

[0097] 2, the transducer circuit 204 includes a single transducer array 206, however, according to some embodiments, the transducer circuit 204 can include one or more, two or more, or three or more separate transducer arrays. In some embodiments, the transducer circuit 204 includes ten or fewer transducer arrays (e.g., nine, eight, seven, six, five, four, three, two, or one transducer array). In some embodiments, the separate transducer arrays can be positioned at different points on the subject and can communicate with the same or different implantable devices 240. In some embodiments, the transducer arrays can be positioned on opposite sides of an implantable device, such as implantable device 242.

[0098] In some embodiments, the specific design of the transducer array 206 of the interrogator 202 depends on the desired penetration length, aperture size, and size of the individual ultrasound transducers 208 in the transducer array 206. The Rayleigh range R of the transducer array 206 is calculated as follows: (Formula) where D is the aperture size and λ is the wavelength of ultrasound in the propagation medium (i.e., tissue). As understood in the art, the Rayleigh distance is the distance at which the beam emitted by the transducer array 206 is fully formed; that is, the pressure field converges to a natural focal point at the Rayleigh distance to maximize the received power. Thus, in some embodiments, the implantable device 240 can be approximately the same distance from the transducer array 206 as the Rayleigh distance.

[0099] Individual ultrasonic transducers 208 in the transducer array 206 can be modulated to control the Rayleigh distance and the position of the beam of ultrasonic waves emitted by the transducer array 206 through a process of beamforming or beamsteering. Techniques such as linearly constrained minimum variance (LCMV) beamforming can be used to communicate multiple implantable devices 240 (e.g., implantable device 242) with an external ultrasonic transceiver. See, for example, Bertrand et al., Beamforming Approaches for Untethered, Ultrasonic Neural Dust Motes for Cortical Recording: a Simulation Study, IEEE EMBC (Aug. 2014). In some embodiments, beamsteering is performed by adjusting the power or phase of the ultrasonic waves emitted by the ultrasonic transducers 208 in the transducer array 206.

[0100] In some embodiments, the interrogator 202 (e.g., the computational circuitry 210) includes one or more of instructions for beam steering ultrasound using one or more ultrasonic transducers 208, instructions for determining the relative position of one or more implantable devices 240, instructions for monitoring the relative movement of one or more implantable devices 240, instructions for recording the relative movement of one or more implantable devices 240, and instructions for deconvolving backscatter from multiple implantable devices 240.

[0101] In some embodiments, the interrogator 202 includes a user interface (not shown) that allows a user (e.g., a physician or patient) to control the operation of the interrogator 202 and to power or communicate with the implantable device 240. In some embodiments, the user interface may include input devices that provide input to the interrogator 202, such as a touch screen or monitor, a keyboard, a mouse, or a voice recognition device. In some embodiments, the user interface may include output devices, such as a touch screen, a monitor, a printer, a disk drive, or any suitable device that provides output, such as a speaker.

[0102] In some embodiments, the interrogator 202 may be controlled using a separate computer system (not shown), such as a mobile device (e.g., a smartphone or tablet). The computer system may wirelessly communicate with the interrogator 202, for example, via a network connection, a radio frequency (RF) connection, or Bluetooth. The computer system may, for example, turn the interrogator 202 on or off, or analyze information encoded in ultrasound waves received by the interrogator 202.

[0103] In some embodiments, the interrogator 202 communicates with multiple implantable devices 240. This can be done, for example, using multiple-input multiple-output (MIMO) systems theory. For example, communication between the interrogator 202 and the multiple implantable devices 240 can be performed using time division multiplexing, spatial multiplexing, or frequency multiplexing. The interrogator 202 can receive combined ultrasound backscatter from the multiple implantable devices 240, which it can deconvolute, thereby extracting information from each implantable device 242. In some embodiments, the interrogator 202 can be configured to focus ultrasound transmitted from the transducer array 206 to a particular implantable device via beam steering. For example, the interrogator 202 can focus transmitted ultrasound on a first implantable device (e.g., implantable device 242) and receive backscatter from the first implantable device, and focus transmitted ultrasound on a second implantable device and receive backscatter from the second implantable device. In some embodiments, the interrogator 202 transmits ultrasound to multiple implantable devices 240 and then receives ultrasound backscatter from the multiple implantable devices 240.

[0104] In some embodiments, the interrogator 202 or one or more ultrasound transducers 208 are wearable. For example, the interrogator 202 or one or more ultrasound transducers 208 may be secured to the subject's body by straps or adhesives. In another example, the interrogator 202 may be a wand that may be held by a user (such as a medical professional). In some embodiments, the interrogator 202 may be held to the body via sutures, simple surface tension, a garment-based fastening device such as a fabric wrap, a sleeve, an elastic band, or by subcutaneous fastening. In some embodiments, the one or more ultrasound transducers 208 or transducer array 206 of the interrogator 202 may be located separately from the remainder of the interrogator 202. For example, the transducer array 206 may be secured to the subject's skin at a first location (e.g., proximal to one or more implant devices) and the remainder of the interrogator 202 may be positioned at a second location with the ultrasound transducer 208 or transducer array 206 tethered to the remainder of the interrogator 202 with a wire.

[0105] 3 illustrates a method 300 for controlling power provided by an interrogator 302 to an implantable device 304, according to some embodiments. In some embodiments, the interrogator 302 and the implantable device 304 may be examples of the implantable device 104 of FIG. 1 and the interrogator 202 of FIG. 2, respectively. Thus, for ease of explanation, the various steps below may refer to components of the implantable device 104 or the interrogator 202.

[0106] At step 306, the interrogator 302 sets one or more ultrasound settings (e.g., ultrasound settings 218). In some embodiments, the ultrasound settings include a command to select a waveform from a plurality of stored waveforms. For example, the waveform may be stored in a data table in a non-transitory memory (e.g., memory 216 or delay control 226). In some embodiments, the ultrasound settings include wave parameters of the ultrasound waves transmitted by the interrogator 302. For example, the wave parameters may include duration, frequency, amplitude (i.e., intensity), wavelength, pulse duration, pulse repetition rate, etc. In some embodiments, the interrogator 302 sets multiple ultrasound settings corresponding to the multiple wave parameters.

[0107] In step 308, the interrogator 302 transmits a powering ultrasonic wave having a wave power. In some embodiments, the interrogator 302 may be configured to generate the powering ultrasonic wave based on one or more ultrasonic settings set in step 306. Thus, the wave power may depend on one or more ultrasonic settings.

[0108] In some embodiments, the transmitted powering ultrasound may include a pulse width modulated (PWM) signal. In these embodiments, the one or more ultrasound settings may include information related to an instantaneous intensity value of the PWM signal, a pulse width of the PWM signal, or a combination thereof. By selecting or setting one or more ultrasound settings, the interrogator 302 may be configured to adjust the wave power of the transmitted powering ultrasound.

[0109] In some embodiments, the interrogator 302 may be configured to transmit a separate ultrasound to the implantable device 304 to request information from the implantable device 304 regarding whether more or less power should be transmitted to the implantable device 304. For example, at step 310, the interrogator 302 transmits a communication ultrasound to the implantable device 304. In some embodiments, the communication ultrasound may be separate from the powering ultrasound of step 308 and may correspond to an ultrasound setting that is different from the setting of the powering ultrasound. In some embodiments, the control circuitry (e.g., control circuitry 212) of the interrogator 302 may be configured to determine the type of ultrasound to transmit (e.g., powering ultrasound or communication ultrasound) based on user input received at the interrogator 202 or based on information transmitted from the implantable device 304.

[0110] At step 316, the implantable device 304 receives the powering ultrasound from the interrogator 302 using the powering ultrasound having wave power. In some embodiments, an ultrasonic transducer (e.g., ultrasonic transducer 108) of the implantable device 304 may be configured to receive the powering ultrasound. In some embodiments, the implantable device 304 may include two or more ultrasonic transducers configured to receive corresponding portions of the powering ultrasound. As discussed above, according to some embodiments, implementing two or more ultrasonic transducers may enable the implantable device 304 to more consistently and efficiently extract power from the powering ultrasound.

[0111] At step 318, the implantable device 304 converts energy from the powering ultrasound into an electrical signal to power the implantable device 304. In some embodiments, the implantable device 304 includes one or more ultrasound transducers (e.g., ultrasound transducer 108) configured to convert mechanical energy of the powering ultrasound received by the implantable device 304 into an electrical signal having electrical energy. In some embodiments, the implantable device 304 may be powered entirely based on the powering ultrasound generated by the interrogator 302.

[0112] In step 320, the implantable device 304 transmits information to the interrogator 302 indicating whether more or less power should be transmitted to the implantable device 304. In some embodiments, control circuitry (e.g., control circuitry 120) of the implantable device 304 may be configured to generate the information. For ease of explanation, the following steps may refer to information such as power information. In some embodiments, step 320 may include one or more of steps 322-330.

[0113] At step 322, the implantable device 304 receives the communication ultrasound from the interrogator 302. In some embodiments, an ultrasound transducer (e.g., ultrasound transducer 108) can be configured to generate an electrical signal based on the received communication ultrasound. In some embodiments, a demodulation circuit (e.g., in the modulation and demodulation circuitry 112) of the implantable device 304 can be configured to extract instructions from the communication ultrasound that request the implantable device 304 to transmit power information. For example, the modulation circuitry can demodulate the communication ultrasound to extract the instructions.

[0114] At step 324, the implantable device 304 determines the available power on the implantable device 304. In some embodiments, a power monitor (e.g., power monitor 124) of the implantable device 304 may be configured to determine the available power. In some embodiments, the available power includes power provided by the powering ultrasound as received at the ultrasound transducer (e.g., ultrasound transducer 108) and power accessible (e.g., in power circuit 130) from an energy storage device (e.g., energy storage device 136) on the implantable device 304.

[0115] In some embodiments, as described above with respect to the power circuit 130, the energy storage device can be configured to operate in at least two power modes to allow the implantable device 304 to more efficiently utilize the power of the powering ultrasound and to provide consistent power to the implantable device 304. In some embodiments, the power mode includes a discharge mode in which a portion of the energy stored in the energy storage device is discharged to transfer power from the energy storage device to the implantable device 304 (e.g., one or more load circuits). In some embodiments, the power mode includes a charge mode in which a portion of the power of the powering ultrasound is transferred to an energy storage device that can store energy.

[0116] In some embodiments, the power monitor can be configured to determine the available power based on determining a maximum voltage (i.e., open circuit voltage) provided by the ultrasonic transducer. In some embodiments, the maximum voltage corresponds to a maximum possible voltage of the electrical signal. In some embodiments, the implantable device 304 includes a voltage sensor configured to measure data corresponding to a maximum voltage of the ultrasonic transducer. For example, the voltage sensor may be a voltage divider coupled to the electrical signal. In some embodiments, the power monitor can determine the maximum voltage based on data received from the voltage sensor.

[0117] In some embodiments, the power monitor may be configured to determine the available power based on the energy stored in the energy storage device. For example, the power monitor may determine the stored energy based on a voltage or current of the energy storage device measured by a sensor. In some embodiments, the power monitor is configured to determine the available power based on a rate of change of the energy stored in the energy storage device.

[0118] In some embodiments, the implantable device 304 includes a power conveyor circuit (e.g., power conveyor circuit 134) configured to convert a first voltage associated with an electrical signal, as generated by an ultrasonic transducer, to a second voltage for powering the implantable device 304 and a load circuit. In some embodiments, the power conveyor circuit includes a charge pump configured to convert the first voltage to a second voltage having a magnitude greater than the first voltage. In some embodiments, the control circuit can be configured to control one or more switches of the charge pump to control a plurality of capacitors (of the charge pump) to generate the second voltage. As discussed above, this conversion may be necessary because the strength of the powering ultrasound may be limited below a certain value (e.g., by government regulations) to ensure human safety, resulting in the first voltage being too low to power the load circuit of the implantable device 304. In some embodiments, the power monitor can be configured to determine the available power based on a switch frequency of at least one of the one or more switches of the charge pump.

[0119] At step 326, the implantable device 304 determines the power consumption at the implantable device 304. In some embodiments, a power monitor (eg, power monitor 124) of the implantable device 304 may be configured to determine the power consumption.

[0120] In some embodiments, the power consumption can include power consumed by one or more load circuits on the implantable device 304. In some embodiments, to determine the power consumption, the power monitor can be configured to detect a current value of a current driving one or more load circuits of the implantable device 304. For example, the power monitor can receive data indicative of the current value from a current sensor.

[0121] In some embodiments, the implantable device 304 may determine the power consumption based on the operating mode of the implantable device 304. In some embodiments, the implantable device 304 may be configured to store an estimated power consumption corresponding to each operating mode in a non-transitory memory (e.g., memory 126). For example, the implantable device 304 may include a neural stimulation mode and a temperature recording mode. Because in this example inducing electrical pulses to stimulate nerves requires more power than storing detected temperatures, the implantable device 304 may store a higher estimated power consumption for the neural stimulation mode than the temperature recording mode.

[0122] At step 328, the implantable device 304 generates power information based on the available power and the consumed power. In some embodiments, the power information includes information indicative of the available power, the consumed power, or a combination thereof.

[0123] In some embodiments, the power information may include a request for either more power or less power and is generated based on available power and consumed power. In some embodiments, the power information may include a request to maintain the same power. In some embodiments, the power information may include a request indicating an amount of power to be increased or decreased. For example, a power monitor (e.g., power monitor 124) of the implantable device 304 may be configured to compare the available power with the power consumed to generate the request. In some embodiments, the implantable device 304 may generate the power information by performing the method 400 of FIG. 4, as described below.

[0124] In step 330, the implantable device 304 emits ultrasonic backscatter that encodes the power information and ultrasonic backscatter of the communication ultrasonic wave. In some embodiments, the control circuitry can be configured to control modulation circuitry of the implantable device 304 (e.g., in the modulation / demodulation circuitry 112) to modulate a current provided by an electrical signal corresponding to the communication ultrasonic wave to encode the power information. In some embodiments in which the implantable device 304 includes multiple ultrasonic transducers, the control circuitry can be configured to select one or more of the ultrasonic transducers to emit ultrasonic backscatter with encoded information. In some embodiments, the control circuitry can be configured to select one or more ultrasonic transducers based on one or more transducer parameters. For example, such transducer parameters may include voltage, current, power, etc.

[0125] At step 312, the interrogator 302 (e.g., transducer circuitry 204) receives power information from the implantable device 304. In some embodiments, the interrogator 302 may be configured to receive ultrasonic backscatter corresponding to the transmitted communication ultrasonic waves of step 310. In some embodiments, a data processor (e.g., data processor 211) of the interrogator 302 may be configured to extract the power information from the ultrasonic backscatter received at one or more ultrasonic transducers of the interrogator 302.

[0126] In step 314, the interrogator 302 determines whether to adjust the wave power based on the power information. In some embodiments, to adjust the wave power, the control circuitry (e.g., control circuitry 212) of the interrogator 302 may be configured to set one or more ultrasonic settings to control the wave power to correspond to the power information. For example, as shown in FIG. 3, the method 300 returns to step 306. Thereafter, according to some embodiments, the interrogator 302 may generate and transmit a second powering ultrasonic wave having a second wave power based on the power information. The implantable device 304 may then receive the second powering ultrasonic wave at the second wave power to enable safe operation and consistent power.

[0127] In some embodiments, the power information includes a request for more or less power to be transmitted to the implantable device 304. In these embodiments, the control circuitry can be configured to set one or more ultrasonic settings to control the wave power to correspond to the request. For example, if the request is for more power, the interrogator 302 may increase an instantaneous intensity value (i.e., one example of an ultrasonic setting), increase a pulse width (i.e., another example of an ultrasonic setting), or increase both the instantaneous intensity value and the pulse width.

[0128] In some embodiments, the power information includes information indicative of available power and consumed power of the implantable device 304. In these embodiments, the control circuitry may be configured to determine, based on the power information, whether more or less power should be transmitted to the implantable device 304. In some embodiments, the control circuitry of the interrogator 302 may be configured to make such a determination by performing the method 400 of FIG. 4, as described below.

[0129] In some embodiments, as described above, the powering ultrasonic wave may be transmitted as a PWM signal. In some embodiments, to control the wave power of the powering ultrasonic wave, the interrogator 302 may be configured to set one or more ultrasonic settings, such as an instantaneous intensity value or a pulse width of the PWM signal. In some embodiments, the interrogator 302 may be configured to set both the instantaneous intensity value and the pulse width of the PWM signal.

[0130] FIG. 4 illustrates a method 400 for determining information indicative of whether more or less power should be transmitted from an interrogator to an implantable device, according to some embodiments. In some embodiments, the implantable device may be an example of the implantable device 104 of FIG. 1 or the implantable device 304 of FIG. 3. In some embodiments, the interrogator may be an example of the interrogator 202 of FIG. 2 or the interrogator 302 of FIG. 3. In some embodiments, the method 400 may be performed in the implantable device, as described further below. In other embodiments, the method 400 may be performed in the interrogator, as described further below. For ease of explanation, the various steps of the method 400 below may refer to components of the implantable device 104 as described with respect to FIG. 1, components of the interrogator as described with respect to FIG. 2, or steps of the method 300 as described with respect to FIG. 3.

[0131] In step 402, the power consumption (Pc) of the implantable device and the supply power (Ps) associated with the first voltage and the implantable device are monitored. As described above with respect to step 318, an ultrasonic transducer of the implantable device can convert energy from the received powering ultrasonic waves into an electrical signal to power the implantable device. In some embodiments, the supply power corresponds to the power provided by the electrical signal, as described above in step 324.

[0132] In some embodiments, the implantable device can be configured to determine the supplied power based on the electrical signal generated by the ultrasonic transducer. In some embodiments, a power monitor (e.g., power monitor 124) can be configured to determine the supplied power based on determining a maximum voltage (i.e., open circuit voltage) provided by the ultrasonic transducer. In some embodiments, the maximum voltage corresponds to a maximum possible voltage of the electrical signal. In some embodiments, the implantable device includes a voltage sensor configured to measure data corresponding to a maximum voltage of the ultrasonic transducer. For example, the voltage sensor may be a voltage divider coupled to the electrical signal. In some embodiments, the power monitor can determine the maximum voltage based on data received from the voltage sensor.

[0133] In some embodiments, the implantable device may be configured to determine power consumption based on an operating mode of the implantable device. In some embodiments, the implantable device may be configured to dynamically determine the power consumption of the implantable device based on one or more detected voltages or currents of one or more load circuits of the implantable device.

[0134] In some embodiments, the implantable device includes a power conveyor circuit (e.g., power conveyor circuit 134) that receives a first voltage at a first voltage node based on the electrical signal and converts the first voltage to a second voltage to power the implantable device. For example, the power conveyor circuit may include a charge pump that controls a plurality of capacitors to provide a second voltage that is greater in magnitude than the first voltage. As described above, the second voltage may be required because the first voltage provided by the electrical signal generated from the powering ultrasound may be too low to operate various electronic components (e.g., transistors). In some embodiments, the power conveyor circuit generates an output electrical signal having a second voltage to power a load circuit of the implantable device. In these embodiments, the implantable device may be configured to determine power consumption based on the second voltage and the current of the output electrical signal. Thus, according to some embodiments, the power consumed may be associated with the second voltage provided by the power conveyor circuit.

[0135] In some embodiments in which the method 400 is performed in an interrogator, the interrogator may receive power information from the implantable device indicating power supply and power consumption.

[0136] At step 404, it is determined whether the supplied power exceeds the power consumption. If it is determined that the supplied power exceeds the power consumption, the method 400 proceeds to step 414. Otherwise, the method 400 proceeds to step 406. In some embodiments, the implantable device (e.g., the power monitor 124) may be configured to compare the monitored supplied power to the monitored power consumption to make this determination.

[0137] In some embodiments in which method 400 is performed in an interrogator, the interrogator may receive power information from the implantable device indicating the power supplied and the power consumed. Based on this information, the interrogator (e.g., control circuit 212) may perform a similar comparison to determine whether the power supplied exceeds the power consumed.

[0138] At step 406, it is determined whether the energy storage device of the implantable device is depleted. In some embodiments, the energy storage device may be determined to be depleted if there is information indicating that the amount of energy stored in the energy storage device is below a first predetermined level. In some embodiments in which the energy storage device includes a capacitor, the implantable device may determine information corresponding to the amount of stored energy based on the current voltage (V) of the capacitor. This may be because the energy (E) stored in the capacitor is a function of the capacitance (C) of the capacitor and the current (V) of the capacitor (e.g., E=½CV). 2 ). In some embodiments, the implantable device may compare the energy storage device information (e.g., voltage) to a first predetermined level to determine if the energy storage device is depleted. If it is determined that the energy storage device is depleted, method 400 proceeds to step 408. Otherwise, method 400 proceeds to step 410.

[0139] In some embodiments where method 400 is performed in an interrogator, the interrogator may perform a similar comparison between the energy storage device information and the first predetermined level, as described above. For example, as described above with respect to step 312, the interrogator may extract information from ultrasonic backscatter emitted by the implantable device.

[0140] In step 408, the implantable device is reset. In some embodiments, the implantable device may generate an alarm indicating a power on reset (POR) condition because there is not enough available power at the implantable device to power the load circuitry. In some embodiments, this alarm may be included in the information sent to the interrogator, as described above with respect to step 320.

[0141] In some embodiments, when method 400 is performed at the interrogator, the interrogator may receive power information from the implantable device, including an alarm indicating a POR condition. In some embodiments, based on the alarm, the interrogator may be configured to select one or more wave parameters for retransmitting a powering ultrasound to power the implantable device. For example, the alarm may cause the interrogator to transmit a powering ultrasound for a predetermined amount of time to resume a power-on or start-up mode of the implantable device. In some embodiments, the power mode may include resetting counters and setting operational logic (e.g., FSM states) to an initialized state.

[0142] In step 410, energy is drawn from the energy storage device to power the implantable device. As described above with respect to FIG. 1, according to some embodiments, the energy storage device can be configured to operate in at least two power modes to allow the implantable device to more efficiently utilize the power of the powering ultrasound and to provide consistent power to the load circuit. In some embodiments, the power modes include a discharge mode in which partial energy stored in the energy storage device is discharged to carry power from the energy storage device to power one or more load circuits of the implantable device.

[0143] In some embodiments, the implantable device's control circuitry (e.g., control circuit 120) can be configured to control the power conveyor circuit to discharge the energy storage device to draw energy. In some embodiments, the energy storage device can be configured to be electrically coupled to the power conveyor circuit such that discharging the energy storage device increases a first voltage at a first voltage node of the power conveyor circuit.

[0144] In some embodiments, the power conveyor circuit can be configured to operate the energy storage device in a discharge mode. In some embodiments, the energy storage device can be periodically monitored for depletion, and the power conveyor circuit can be configured to convey power from the energy storage device as long as it is not depleted.

[0145] In some embodiments where method 400 is performed in an interrogator, the interrogator may generate instructions requesting the implantable device to control a power conveyor circuit to discharge an energy storage device to extract energy. In some embodiments, the interrogator may be configured to communicate with the implantable device by encoding instructions in communication ultrasound transmitted by an ultrasonic transducer circuit (e.g., ultrasonic transducer circuit 204).

[0146] At step 412, information indicating that more power is needed is generated. In some embodiments, the implantable device may be configured to generate the power information as described above with respect to step 320. For example, the power information may include a request for more power to be transmitted to the implantable device. In another example, the power information may include an amount of additional power to be provided by the implantable device. The power information may then be transmitted to the interrogator, which is configured to generate a second power wave having a second wave force corresponding to the power information indicating more needed power, as described above with respect to FIG. 3. In some embodiments, the method 400 returns to step 402, where the supplied power and the consumed power are monitored.

[0147] In some embodiments in which the method 400 is performed in an interrogator, the interrogator may generate information associated with one or more ultrasound settings to increase the power of the transmitted powering ultrasound waves.

[0148] At step 414, it is determined whether the energy storage device of the implantable device should be charged. In some embodiments, it may be determined to charge the energy storage device if the implantable device does not have a fully charged energy storage device.

[0149] In some embodiments, step 414 may correspond to step 406, where the same determination is made, as described above. In some embodiments, if there is information indicating that the amount of energy stored in the energy storage device is below a first predetermined level, it may be determined that the energy storage device is depleted and therefore not fully charged. If it is determined that the energy storage device is depleted, method 400 proceeds to step 416. Otherwise, method 400 proceeds to step 420.

[0150] In some embodiments, the energy storage device may be determined to be fully charged if the information indicates that the amount of energy stored in the energy storage device exceeds a second predetermined level. In some embodiments, the second predetermined level exceeds the first predetermined level. In some embodiments, the energy storage device includes a capacitor, the implantable device may determine the information corresponding to the amount of stored energy based on the current voltage (V) of the capacitor. This is because the energy (E) stored in the capacitor is a function of the capacitance (C) of the capacitor and the current (V) of the capacitor (e.g., E=1 / 2CV). 2 ). In some embodiments, the implantable device may compare the energy storage device information (e.g., voltage) to a second predetermined level to determine if the energy storage device is fully charged. If it is determined that the energy storage device is fully charged, method 400 proceeds to step 420. Otherwise, method 400 proceeds to step 416.

[0151] In some embodiments, the power conveyor circuit can be configured to operate the energy storage device in a charging mode. In some embodiments, the energy storage device can be periodically monitored for full charge, and the power conveyor circuit can be configured to convey a portion of the supplied power to charge the energy storage device as long as the energy storage device is not fully charged.

[0152] In some embodiments where method 400 is performed in an interrogator, the interrogator may perform a similar comparison between the energy storage device information and the first or second predetermined level, as described above. For example, as described above with respect to step 312, the interrogator may extract information from ultrasonic backscatter emitted by the implantable device.

[0153] In step 416, the energy storage device is charged. In some embodiments, as described above with respect to Figure 1, the energy storage device can be configured to operate in at least two power modes to allow the implantable device to more efficiently utilize the power of the powering ultrasound and to provide consistent power to the load circuit. In some embodiments, the power modes include a charging mode in which a portion of the supplied power is delivered to an energy storage device that can store energy.

[0154] In some embodiments, the control circuit can be configured to control the power conveyor circuit to charge the energy storage device to utilize excess power provided by the power supply. In some embodiments, the energy storage device can be configured to be electrically coupled to the power conveyor circuit such that charging the energy storage device reduces a first voltage at a first voltage node of the power conveyor circuit.

[0155] In some embodiments where method 400 is performed in an interrogator, the interrogator may generate instructions requesting the implantable device to control a power conveyor circuit to charge an energy storage device to take advantage of the excess power source. In some embodiments, the interrogator may be configured to communicate with the implantable device by encoding instructions in communication ultrasound transmitted by an ultrasonic transducer circuit (e.g., ultrasonic transducer circuit 204).

[0156] In step 420, it is determined whether the first voltage exceeds a predetermined voltage level. In some embodiments, the predetermined voltage level corresponds to a maximum allowable power supply voltage (e.g., less than 4V, less than 5V, or 6V) to maintain safe operation of the implantable device. By maintaining the first voltage below the predetermined voltage level, the implantable device may be protected from overheating and / or damage to electrical components within the implantable device. In some embodiments, the control circuitry of the interrogator may be configured to determine whether the first voltage exceeds the predetermined voltage level. If it is determined that the first voltage exceeds the predetermined voltage level, the method 400 proceeds to step 422. If not, the method 400 proceeds to step 424.

[0157] In some embodiments in which method 400 is performed in an interrogator, the interrogator may perform a similar comparison between the first voltage and a predetermined voltage level, as described above. For example, the interrogator may extract information from ultrasonic backscatter emitted by the implantable device, as described above with respect to step 312, which information may include the first voltage.

[0158] In step 422, the power supply is reduced in the implantable device. In some embodiments, the implantable device can be configured to generate an electrical signal from the powering ultrasound to control one or more switches configured to reduce the power supply. In some embodiments, the one or more switches include a switch for controlling a rectifier circuit that converts the electrical signal in an alternating current (AC) form to a direct current (DC) form corresponding to the first voltage. In some embodiments, the implantable device can be configured to open the switch such that the power source does not supply power to the load circuit of the implantable device. In some embodiments, the one or more switches can include a switch configured to shunt the ultrasound transducer. In some embodiments, the amount of backscatter energy can be modified to reduce the power supply by shunting the leads of the ultrasound transducer (e.g., causing a short circuit).

[0159] At step 424, information indicative of less power required is generated. In some embodiments, the implantable device may be configured to generate the power information as described above with respect to step 320. For example, the power information may include a request for less power to be transmitted to the implantable device. In another example, the power information may include a reduced amount of power to be provided by the implantable device. The power information may then be transmitted to the interrogator, configured to generate a second power wave having a second wave power corresponding to the power information indicative of less required power, as described above with respect to FIG. 3. In some embodiments, the method 400 returns to step 402, where the supplied power and the consumed power are monitored.

[0160] In some embodiments where the method 400 is performed in an interrogator, the interrogator may generate information related to one or more ultrasound settings to power the ultrasound waves and reduce the transmitted wave power.

[0161] FIG. 5 illustrates a diagram 500 of an implantable device 511 configured to interact with a nerve 514 of a subject, according to some embodiments. In some embodiments, the implantable device 511 may be an exemplary implementation of the implantable device 104 as described above with respect to FIG. 1. As shown in FIG. 500, the implantable device 511 may be implanted on the nerve 514 and may include one or more curved members, such as a curved member 502 extending from a body 512. The body 512 of the implantable device 511 may include an integrated circuit 524 (e.g., including the modulation / demodulation circuit 112, the stimulation circuit 114, the detection circuit 116, or the control circuit 120), a non-transitory memory 526 (e.g., the memory 126), a power circuit 528 (e.g., the power circuit 130), and an ultrasound transducer 530 (e.g., the ultrasound transducer 108 or the ultrasound transducer circuit 106). In some embodiments, the body 512 includes multiple ultrasound transducers, including the ultrasound transducer 530. Thus, it should be understood that ultrasonic transducer 530 as shown in diagram 500 may represent multiple ultrasonic transducers.

[0162] In some embodiments, ultrasonic transducer 530 may be configured to receive ultrasonic waves transmitted by an interrogator (e.g., interrogator 102 of FIG. 1 or interrogator 202 of FIG. 2) and convert the mechanical energy of the ultrasonic waves into electrical energy to power implantable device 511. For example, ultrasonic transducer 530 may convert the mechanical energy of the ultrasonic waves into an electrical signal that is processed by power circuitry 528.

[0163] In some embodiments, the power circuitry 528 may include a power conveyor circuit (e.g., power conveyor circuit 134) configured to convert an electrical signal having a first voltage to a second signal having a second voltage to power various components of the integrated circuit 524. In some embodiments, the power circuitry 528 may include a rectifier circuit (e.g., active rectifier) ​​for converting the electrical signal in an AC form to a DC form, where the converted electrical signal may be related to the first voltage. In some embodiments, the power conveyor circuitry may include a charge pump to generate a second voltage greater than the first voltage. In some embodiments, the power circuitry 528 may include an energy storage device (e.g., energy storage device 136) configured to store excess energy provided by the electrical signal and act as a secondary power source when the power provided by the interrogator is insufficient. In some embodiments, the power conveyor circuitry may be configured to control whether power should be transferred to or from the energy storage device, which effectively charges or discharges the energy storage device, respectively. In some embodiments, the power conveyor circuitry can be configured to control the amount of time (e.g., number of clock cycles) that power is conveyed (e.g., forward or reverse) in addition to the direction of power flow.

[0164] In some embodiments, the integrated circuit 524 includes a control circuit (e.g., the control circuit 120) configured to generate information indicative of whether more or less power should be transmitted to the interrogator. In some embodiments, the control circuit may be configured to generate this power information based on the available power provided by the power circuit 528 and the power consumed by the integrated circuit 524. In some embodiments, the available power includes the supplied power provided by the ultrasonic transducer 530 and the accessible power provided by the energy storage device of the power circuit 528. In some embodiments, the control circuit may be configured to control the ultrasonic transducer 530 to transmit the generated power information to the interrogator to cause the interrogator to control the power of the transmitted ultrasonic waves.

[0165] In some embodiments, the power consumption may be determined by the control circuitry based on the mode of operation of the implantable device 511, as described above with respect to Figures 1 and 3. Examples of modes of operation may be a stimulation mode or a detection mode, each of which may operate the electrode pads 518 on the curved member 502.

[0166] In some embodiments, in the detection mode, the electrode pads 518 are configured to detect electrophysiological signals, and detection signals based on the electrophysiological signals are received by the integrated circuit 524. The detection signals received by the integrated circuit 524 may be processed (e.g., amplified, digitized, and / or filtered) by a detection circuit (e.g., detection circuit 116) before being received by the control circuitry. In some embodiments, the control circuitry may access a non-transitory memory (e.g., memory 126) to store data related to the detected electrophysiological signals.

[0167] In some embodiments, in the stimulation mode, the control circuitry can generate a stimulation signal based on the detection signal and operate one or more electrode pads 518 to emit electrical pulses to the nerve 514 based on the stimulation signal. In some embodiments, the control circuitry can access a non-transitory memory (e.g., memory 126) to store data related to the stimulation signal or electrical pulses to be emitted to the nerve 514. The data stored in the non-transitory memory can be wirelessly transmitted via ultrasonic backscatter waves emitted by the ultrasonic transducer 530. As described above with respect to FIG. 1, to transmit data using ultrasonic backscatter, the ultrasonic transducer 530 may first receive ultrasonic waves and generate a current flowing through a modulation circuit. The control circuitry can then access the memory and operate the modulation circuitry to modulate the current flowing through the modulation circuitry to encode the data. Through such a process, the ultrasonic backscatter waves emitted by the ultrasonic transducer 530 can encode the data.

[0168] In some embodiments, as shown in diagram 500, curved member 502 can include a first portion 502a and a second portion 502b bridged by body 512 at point 516. In some embodiments, first portion 502a and second portion 502b are directly connected and curved member 502 is attached to body 512 via a connecting member. Curved member 502 can include multiple electrode pads 518 on an inner surface of curved member 502, which can be radially arranged about an axis parallel to the length of nerve 514. A separation 520 between first portion 202a and second portion 202b exists along curved member 502 (which can exist in other curved members of implantable device 511 as well). In some embodiments, the implantable device 511 can be implanted by bending the first portion 502a and the second portion 502b of the curved member 502 outward, thereby expanding the size of the separation and allowing the nerve 514 or other thread-like tissue to pass through the separation 520 and fit within the cylindrical space formed by the curved member 502. The first portion 502a and the second portion 502b of the curved member 502 can be released, which allows the curved member 502 to wrap around the nerve 514 or other thread-like tissue.

[0169] A plurality of electrode pads 518 as shown in FIG. 5 are external to the nerve 514 but in direct contact with the epineurium of the nerve 514. The nerve 514 may include several fiber bundles 522. In some embodiments, the electrode pads 518 in the curved member 502 may be operated for targeted emission of electrical pulses to one or more fiber bundles 522 or other subsets of nerve fibers and / or for targeted detection of electrophysiological signals transmitted by one or more fiber bundles 522 or other subsets of nerve fibers. For example, the electrode pads 518 may be selectively actuated by a control circuit in an integrated circuit 524 housed in the body 512 to emit electrical pulses targeted to one or more fiber bundles 522. In another example, the electrode pads 518 are operated by the control circuit to detect electrophysiological signals transmitted by one or more fiber bundles 522 in the nerve 514. In some embodiments, the curved member 502 may be configured to detect electrophysiological signals transmitted by the nerve 514 or a subset of nerve fibers, or to emit electrical pulses to the nerve 514 or to be targeted to a subset of nerve fibers, or to detect electrophysiological signals transmitted by the nerve 514 or a subset of nerve fibers and to emit electrical pulses to the nerve 514 or to be targeted to a subset of nerve fibers. For example, the implantable device 511 may include multiple curved members (including the curved member 502), where a first curved member may be configured to detect electrophysiological signals transmitted by the nerve 514 or a subset of nerve fibers and a second curved member may be configured to emit electrical pulses to the nerve 514 or to target a subset of nerve fibers.

[0170] In some embodiments, the curved member 502 can be sized to engage a selected nerve 514 or fibrous tissue that includes the nerve 514. The nerve 514 can be a spinal or peripheral nerve. In some embodiments, the nerve 514 is an autonomic or somatic nerve. In some embodiments, the nerve 514 is a sympathetic or parasympathetic nerve. In some embodiments, the nerve 514 is a vagus nerve, mesenteric nerve, splenic nerve, sciatic nerve, tibial nerve, pudendal nerve, celiac ganglion, sacral nerve, or any branch thereof.

[0171] The size, shape, and spacing of the curved members 502 on the implantable device 511 may depend on the type and size of tissue that the implantable device 511 engages. In some embodiments, two or more curved members of the implantable device 511 are spaced apart by about 0.25 mm or more (e.g., about 0.5 mm or more, about 1 mm or more, about 2 mm or more, about 3 mm or more, about 4 mm or more, about 5 mm or more, about 6 mm or more, or about 7 mm or more). In some embodiments, two or more curved members are spaced apart by about 8 mm or less (e.g., about 7 mm or less, about 6 mm or less, about 5 mm or less, about 4 mm or less, about 3 mm or less, about 2 mm or less, about 1 mm or less, or about 0.5 mm or less). By way of example, the two or more curved members may be spaced apart by about 0.25 mm to about 0.5 mm, about 0.5 mm to about 1 mm, about 1 mm to about 2 mm, about 2 mm to about 3 mm, about 3 mm to about 4 mm, about 4 mm to about 5 mm, about 5 mm to about 6 mm, about 5 mm to about 7 mm, or about 7 mm to about 8 mm. The width of the curved members 502 may also vary depending on the application of the implantable device 511 or the tissue to be engaged by the implantable device 511. In some embodiments, the width of the curved members 502 is about 100 μm or more (e.g., about 150 μm or more, about 250 μm or more, about 500 μm or more, about 1 mm or more, or about 1.5 mm or more). In some embodiments, the width of the curved members 502 is about 2 mm or less (e.g., about 1.5 mm or less, about 1 mm or less, about 500 μm or less, about 250 μm or less, or about 150 μm or less). In some embodiments, the width of the curved member 502 is about 100 μm to about 2 mm (e.g., about 100 μm to about 150 μm, about 150 μm to about 250 μm, about 250 μm to about 500 μm, about 500 μm to about 1 mm, about 1 mm to about 1.5 mm, or about 1.5 mm to about 2 mm). The inner surface of the curved member 502 forms a cylindrical space through which the nerve 514 and / or threadlike tissue passes. The diameter of the cylindrical space formed by the curved member 502 depends on the target nerve and / or threadlike tissue that the implantable device 511 engages.In some embodiments, curved member 502 forms a cylindrical space having a diameter of about 50 μm to about 15 mm (e.g., about 50 μm to about 100 μm, about 100 μm to about 250 μm, about 250 μm to about 500 μm, about 500 μm to about 1 mm, about 1 mm to about 1.5 mm, about 1.5 mm to about 2.5 mm, about 2.5 mm to about 5 mm, about 5 mm to about 10 mm, or about 10 mm to about 15 mm).

[0172] In some embodiments, the implantable device 511 includes one or more additional fixation members configured to fix the implantable device 511 to the threadlike tissue. Such fixation members may include, for example, loops for suturing the implantable device to an anatomical structure (such as a threadlike tissue or nerve, or other tissue surrounding the threadlike tissue or nerve), pins, or clamps. For example, the implantable device 511 may be sutured to the threadlike tissue or nerve 514, or tissue surrounding the threadlike tissue or nerve, to limit movement of the implantable device 511 once implanted.

[0173] In some embodiments, the curved member 502 of the implantable device 511 can include a metal, a metal alloy, a ceramic, a silicon, or a non-polymeric material. The curved member 502 can be flexible, and preferably is resilient, such that the curved member 502 can be positioned around the nerve 514 and / or thread-like tissue. In some embodiments, the curved member 502 or a portion of the curved member 502 is coated with an elastomeric or non-elastomeric coating, which is preferably bioinert, such as polydimethylsiloxane (PDMS), silicone, a urethane polymer, a poly(p-xylylene) polymer (such as the poly(p-xylylene) polymer sold under the trade name PARYLENE®), or a polyimide. The curved member 502 can include a plurality of electrode pads 518 on an inner surface. In some embodiments, the electrode pads 518 on the inner surface of the curved member 502 are not coated with an elastomeric or non-elastomeric polymer coating, although the inner surface may be coated with a conductive material (e.g., electroplated with a PEDOT polymer or metal to improve the electrical properties of the electrode pads). Thus, in some embodiments, only the outer surface of the curved member 502 is coated with a coating. Optionally, a coating further coats the housing of the body 512.

[0174] In some embodiments, the plurality of electrode pads 518 can include 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more electrode pads, e.g., about 3 to about 50 electrode pads, about 3 to about 5 electrode pads, about 5 to about 10 electrode pads, about 10 to about 25 electrode pads, or about 25 to about 50 electrode pads. In some embodiments, the electrode pads in the plurality of electrode pads 518 can be selectively activated by a control circuit that enables targeted electrical pulse emission, as further described herein.

[0175] In some embodiments, the electrode pads 518 may comprise any suitable conductive material, such as one or more of tungsten, platinum, palladium, gold, iridium, niobium, tantalum, or titanium (or alloys of one or more of them). The data of the detection electrode pads and the stimulation electrode pads may be the same or different. The size and shape of the electrode pads 518 may be the same or different. For example, the electrode pads 518 on a given curved member 502 may be the same or different sizes, and the electrode pads on different curved members may be the same or different sizes.

[0176] In some embodiments, the electrode pad 518 of the implantable device 511 is positioned by the curved member 502 to be in electrical communication with the nerve 514. In some embodiments, the electrode pad 518 is not in direct contact with the nerve 514 (e.g., not indirectly contacting the outside of the nerve 514) but is in electrical communication with the nerve 514. In some embodiments, the electrode pad 518 is positioned within about 2 mm (e.g., within about 1.8 mm, within about 1.6 mm, within about 1.4 mm, within about 1.2 mm, within about 1.0 mm, within about 0.8 mm, within about 0.6 mm, within about 0.4 mm, or within about 0.2 mm) of the nerve 514. In some embodiments, the electrode pad 518 is configured to pierce the epineurium of the nerve 514 at one or more locations. For example, the electrode pad 518 can be needle-shaped to allow for piercing of the epineurium. In some embodiments, the electrode pad 518 directly contacts the nerve 514, e.g., the epineurium of the nerve 514.

[0177] In some embodiments, the body 512 includes a housing, which may include a base, one or more sidewalls, and a top. The housing may enclose the ultrasound transducer 530 and the integrated circuit 524. The housing may be sealed (e.g., by soldering or laser welding) to prevent interstitial fluid from contacting the ultrasound transducer 530 or the integrated circuit 524. The housing is preferably made of a bioinert material, such as a bioinert metal (e.g., steel or titanium) or a bioinert ceramic (e.g., titania or alumina). The housing (or the top of the housing) may be thin to allow ultrasound waves to penetrate the housing. In some embodiments, the housing has a thickness of about 100 micrometers (μm) or less, such as about 75 μm or less, about 50 μm or less, about 25 μm or less, or about 10 μm or less. In some embodiments, the housing has a thickness of about 5 μm to about 10 μm, about 10 μm to about 25 μm, about 25 μm to about 50 μm, about 50 μm to about 75 μm, or about 75 μm to about 100 μm.

[0178] In some embodiments, the body 512 of the implantable device 511 is relatively small, which allows for comfortable and long-term implantation while limiting the tissue inflammation often associated with implantable medical devices. In some embodiments, the longest dimension of the body 512 is about 10 mm or less, such as about 5 mm to about 9 mm, or about 6 mm to about 8 mm.

[0179] In some embodiments, the body 512 includes a material, such as a polymer, within a housing. The material can fill the empty space within the housing to reduce the acoustic impedance mismatch between the exterior of the housing and the tissue within the housing. Thus, according to some embodiments, the body 512 is preferably free of air or vacuum.

[0180] In some embodiments, the ultrasonic transducer 530 may include a micromachined ultrasonic transducer, such as a capacitive micromachined ultrasonic transducer (CMUT) or a piezoelectric micromachined ultrasonic transducer (PMUT), or may include a bulk piezoelectric transducer. Bulk piezoelectric transducers may be any natural or synthetic material, such as quartz, ceramic, or polymer. Bulk piezoelectric transducer materials include barium titanate (BaTiO3), lead zirconate titanate (PZT), zinc oxide (ZO), aluminum nitride (AlN), quartz, belinite (AlPO4), topaz, langasite (La3Ga5SiO4), and other materials. 14 ), gallium orthophosphate (GaPO4), lithium niobate (LiNbO3), lithium tantalate (LiTaO3), potassium niobate (KNbO3), sodium tungstate (Na2WO3), bismuth ferrite (BiFeO3), polyvinylidene (di)fluoride (PVDF), lead niobate-lead titanate (PMN-PT).

[0181] In some embodiments, the bulk piezoelectric transducer is approximately cubic (i.e., an aspect ratio of about 1:1:1 (length:width:height)). In some embodiments, the piezoelectric transducer is plate-like with an aspect ratio of about 5:5:1 or more in either the length or width aspect, such as about 7:5:1 or more, or about 10:10:1 or more. In some embodiments, the bulk piezoelectric transducer is long and narrow, with an aspect ratio of about 3:1:1 or more, with the longest dimension aligned with the direction of the ultrasonic backscatter wave (i.e., the polarization axis). In some embodiments, one dimension of the bulk piezoelectric transducer is equal to ½ of the wavelength (λ) corresponding to the drive frequency or resonant frequency of the transducer. At the resonant frequency, ultrasonic waves impinging on either face of the transducer undergo a phase shift of 180° to reach an antiphase, causing maximum displacement between the two faces. In some embodiments, the height of the piezoelectric transducer is about 10 μm to about 1000 μm (e.g., about 40 μm to about 400 μm, about 100 μm to about 250 μm, about 250 μm to about 500 μm, or about 500 μm to about 1000 μm). In some embodiments, the height of the piezoelectric transducer is about 5 mm or less (e.g., about 4 mm or less, about 3 mm or less, about 2 mm or less, about 1 mm or less, about 500 μm or less, about 400 μm or less, 250 μm or less, about 100 μm or less, or about 40 μm or less). In some embodiments, the height of the piezoelectric transducer is about 20 μm or more in length (e.g., about 40 μm or more, about 100 μm or more, about 250 μm or more, about 400 μm or more, about 500 μm or more, about 1 mm or more, about 2 mm or more, about 3 mm or more, or about 4 mm or more).

[0182] In some embodiments, the ultrasonic transducer 530 has a length of about 5 mm or less in its longest dimension (e.g., about 4 mm or less, about 3 mm or less, about 2 mm or less, about 1 mm or less, about 500 μm or less, about 400 μm or less, 250 μm or less, about 100 μm or less, or about 40 μm or less). In some embodiments, the ultrasonic transducer 530 has a length of about 20 μm or more in its longest dimension (e.g., about 40 μm or more, about 100 μm or more, about 250 μm or more, about 400 μm or more, about 500 μm or more, about 1 mm or more, about 2 mm or more, about 3 mm or more, or about 4 mm or more).

[0183] In some embodiments, the ultrasonic transducer 530 is connected to two electrodes to enable electrical communication with the integrated circuit 524. A first electrode is attached to a first surface of the ultrasonic transducer 530, and a second electrode is attached to a second surface of the ultrasonic transducer 530, with the first surface and the second surface being attached to opposite sides of the ultrasonic transducer 530 along one dimension. In some embodiments, the electrodes comprise silver, gold, platinum, platinum black, poly(3,4-ethylenedioxythiophene (PEDOT)), a conductive polymer (such as conductive PDMS or polyimide), or nickel. In some embodiments, the axis between the electrodes of the ultrasonic transducer 530 is orthogonal to the motion of the ultrasonic transducer 530.

[0184] The foregoing description sets forth exemplary methods, parameters, and the like. However, it should be recognized that such description is not intended as a limitation on the scope of the present disclosure, but is instead provided as a description of exemplary embodiments. The exemplary embodiments described above are not intended to be exhaustive or to limit the disclosure to the precise forms disclosed. Many modifications and variations are possible in light of the above teachings. The embodiments have been chosen and described in order to best explain the principles of the disclosed technology and their practical application. In this way, those skilled in the art can best utilize the technology and various embodiments with various modifications as appropriate to the particular use envisaged.

[0185] Although the present disclosure and examples have been fully described with reference to the accompanying drawings, it should be noted that various changes and modifications will become apparent to those skilled in the art. Such changes and modifications should be understood as being included within the scope of the disclosure and examples as defined by the claims. In the foregoing description of the present disclosure and embodiments, reference is made to the accompanying drawings, which show, by way of example, specific embodiments that can be implemented. It is to be understood that other embodiments and examples can be implemented and changes can be made without departing from the scope of the present disclosure.

[0186] Although the above description uses the terms first, second, etc. to describe various elements, these elements should not be limited by the terms. These terms are only used to distinguish one element from another element.

[0187] As used herein, a reference to "about" or "approximately" a value or parameter includes (and describes) variations directed to the value or parameter itself; for example, a statement referring to "about X" includes a statement of "X."

[0188] It is understood that embodiments and variations of the invention described herein include those that "consist" and / or "consist essentially of".

[0189] The terms "embeddable" and "embedded" refer to an object that is fully embedded or completely embedded in an object such that no part of the object breaks through the surface of the object.

[0190] The term "substantially" refers to 90% or more. For example, a curved member that substantially surrounds a cross-section of a nerve refers to a curved member that surrounds 90% or more of the cross-section of the nerve.

[0191] The terms "subject" and "patient" are used interchangeably herein to refer to a vertebrate animal, such as a human.

[0192] The terms "treat," "treat," and "treating" are used interchangeably herein and refer to any action that provides a benefit to a subject afflicted with a disease state or condition, including ameliorating the condition by reducing, inhibiting, suppressing, or eliminating at least one symptom, slowing the progression of the disease or condition, slowing the recurrence of the disease or condition, or inhibiting the disease or condition.

[0193] When a range of values ​​is provided, it is to be understood that each intervening value between the upper and lower limit of that range, and any other stated or intervening value in that stated range, is encompassed within the scope of the disclosure. Where a stated range includes an upper or lower limit, ranges excluding either of those limits are also included in the disclosure.

[0194] Furthermore, it should be understood that the singular forms "a," "an," and "the," as used in the preceding description, are intended to include the plural forms unless the context clearly dictates otherwise. The term "and / or," as used herein, should also be understood to refer to and include any and all possible combinations of one or more of the associated listed items. Furthermore, it should be understood that the terms "including," "comprising," and / or "comprising," as used herein, specify the presence of stated features, integers, steps, operations, elements, components, components, and / or units, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, units, and / or groups thereof.

[0195] The term "if" can be interpreted to mean "when" or "upon determining" or "upon determining" or "in response to detecting," depending on the context. Similarly, the phrase "whether determined" or "whether a specified condition or event is detected" can be interpreted to mean "upon determining" or "upon determining" or "upon detecting a specified condition or event" or "in response to detecting a specified condition or event," depending on the context.

[0196] The features and preferences described above in connection with the "embodiments" are separate preferences and are not limited to that particular embodiment, but can be freely combined with features from other embodiments where technically feasible to form preferred combinations of features. This description is presented to enable one of ordinary skill in the art to make and use the invention and is provided in the context of a patent application and its requirements. Various modifications to the described embodiments will be readily apparent to those skilled in the art, and the generic principles herein may be applied to other embodiments. Thus, the present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles and features described herein.

Claims

1. 1. A method of controlling power supplied to an implantable device in a subject, comprising: receiving ultrasonic power supply from an interrogator, the ultrasonic power supply having wave power; converting energy from the ultrasonic power supply into an electrical signal for powering the implantable device; transmitting information to the interrogator indicating whether more or less power should be transmitted to the implantable device; The method according to claim 1, further comprising:

2. 2. The method of claim 1, comprising determining power available at the implantable device and power consumption by the implantable device, the information relating to the available power and the power consumption.

3. 3. A method according to claim 1 or 2, wherein said information includes a request from said interrogator for either more power or less power.

4. 4. The method of claim 3, wherein the request is generated based on available power at the implantable device and power consumed by the implantable device.

5. Transmitting the information includes: receiving ultrasonic communication signals from the interrogator; emitting ultrasonic backscatter of the communication ultrasonic wave, the ultrasonic backscatter encoding the information; 5. The method according to claim 1, further comprising:

6. The radiating of the ultrasonic backscatter of the communication ultrasonic wave includes: Generating an electrical signal based on an ultrasonic wave for communication; modulating the generated electrical signal based on the information, the modulated electrical signal encoding the information into ultrasonic backscatter; 6. The method of claim 5, comprising:

7. 7. The method according to claim 1, further comprising receiving a second powering ultrasonic wave from the interrogator, the interrogator being configured to generate the second powering ultrasonic wave having a second wave power based on the information.

8. 8. The method according to claim 1, wherein the ultrasonic power supply comprises a pulse width modulated (PWM) signal.

9. 9. The method of claim 8, wherein the interrogator is configured to adjust an instantaneous intensity value or a pulse width of the PWM signal based on the information.

10. 9. The method of claim 8, wherein the interrogator is configured to adjust the instantaneous intensity value and pulse width of the PWM signal based on the information.

11. The power supply ultrasonic wave is received by an ultrasonic transducer of the implantable device, and determining the available power includes: determining a maximum voltage of the ultrasonic transducer; determining available power based on the maximum voltage; 3. The method of claim 2, comprising:

12. Determining the available power comprises: charging an energy storage device based on the electrical signal; determining the available power based on energy stored in the energy storage device; 3. The method of claim 2, comprising:

13. 13. The method of claim 12, wherein the available power is determined based on a rate of change of the energy stored in the energy storage device.

14. The electrical signal produces a first voltage, and determining the available power includes: controlling one or more switches to control a plurality of capacitors configured to convert the first voltage to a second voltage to power the implantable device; determining the available power based on a switching frequency of at least one of the one or more switches; 3. The method of claim 2, comprising:

15. The method of claim 2 , wherein determining the power consumption comprises determining the power consumption of the implantable device based on an operational mode of the implantable device.

16. The power consumption is consumed by a load circuit of the implantable device, and determining the power consumption includes: Detecting a current value of a current that drives the load circuit; determining the power consumption from the detected current value; 3. The method of claim 2, comprising:

17. 3. The method of claim 2, wherein the available power includes a supply power provided by the electrical signal, the electrical signal producing a first voltage at a first voltage node, and determining whether the supply power exceeds the power consumption.

18. 20. The method of claim 17, further comprising charging an energy storage device based on the first voltage node in response to determining that the supply power exceeds the power consumption, wherein charging the energy storage device reduces the first voltage.

19. 20. The method of claim 18, comprising determining whether the energy storage device is fully charged.

20. 20. The method of claim 19, further comprising, in response to determining that the supply power exceeds the power consumption and that the energy storage device is fully charged, transmitting the information to the interrogator including an indication that the implantable device is over-powered.

21. 21. The method of claim 20, wherein the information including the instructions is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power less than the wave power of the powering ultrasonic wave.

22. determining whether the first voltage exceeds a predetermined voltage level; In response to determining that the first voltage exceeds the predetermined voltage level and the energy storage device is fully charged, opening one or more switches configured to generate the electrical signal from the powering ultrasonic wave to reduce the supply power; 20. The method of claim 19, comprising:

23. 20. The method of claim 18, further comprising discharging the energy storage device via the first voltage node in response to determining that the supply power is less than the power consumption, wherein discharging the energy storage device increases the first voltage.

24. 20. The method of claim 17, further comprising, in response to determining that the supplied power is less than the consumed power, transmitting the information to the interrogator including an indication that the implantable device is underpowered.

25. 25. The method of claim 24, wherein the information including the instructions is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power greater than the wave power of the powering ultrasonic wave.

26. 1. An implantable device comprising: an ultrasonic transducer configured to receive ultrasonic power from an interrogator, convert the ultrasonic power into an electrical signal, and supply power to the implantable device, the ultrasonic power having a wave force; a control circuit configured to generate information indicative of whether more or less power should be transmitted to the implantable device; wherein the ultrasound transducer is further configured to transmit the information to the interrogator.

27. 27. The device of claim 26, comprising a power monitor circuit configured to determine power available at the implantable device and to determine power consumption by the implantable device.

28. 28. A device as claimed in claim 26 or 27, wherein said information includes a request for more or less power from the interrogator.

29. 30. The device of claim 28, wherein the request is generated based on available power at the implantable device and power consumption by the implantable device.

30. To transmit the information, the ultrasonic transducer receiving ultrasonic waves for communication from the interrogator; emitting ultrasonic backscatter of the communication ultrasonic wave, the ultrasonic backscatter encoding the information; 30. A device according to any one of claims 26 to 29, configured to:

31. In order to radiate the ultrasonic backscatter of the communication ultrasonic wave, the ultrasonic transducer Generate an electrical signal based on the communication ultrasonic wave; modulating the generated electrical signal based on the information, the modulated electrical signal encoding the information into the ultrasonic backscatter.

31. The device of claim 30, configured to:

32. 32. The device of any one of claims 26 to 31, wherein the ultrasonic transducer is configured to receive a second powering ultrasonic wave from the interrogator, and the interrogator is configured to generate the second powering ultrasonic wave having a second wave power based on the information.

33. 33. The device of any one of claims 26 to 32, wherein the powering ultrasonic wave comprises a pulse width modulated (PWM) signal.

34. 34. The device of claim 33, wherein the interrogator is configured to adjust an instantaneous intensity value or a pulse width of the PWM signal based on the information.

35. 35. The device of claim 34, wherein the interrogator is configured to adjust the instantaneous intensity value and pulse width of the PWM signal based on the information.

36. a voltage sensor configured to determine a maximum voltage of the ultrasonic transducer; 30. The device of claim 27, wherein the power monitor circuit is configured to determine available power based on the maximum voltage.

37. 30. The device of claim 27, further comprising a power conveyor circuit configured to charge an energy storage device based on the electrical signal, the power monitor circuit configured to determine the available power based on energy stored in the energy storage device.

38. 40. The device of claim 37, wherein the power monitor circuit is configured to determine the available power based on a rate of change of the energy stored in the energy storage device.

39. the electrical signal produces a first voltage; the control circuitry is configured to control one or more switches to control a plurality of capacitors configured to convert the first voltage to a second voltage to power the implantable device; 30. The device of claim 27, wherein the power monitor circuit is configured to determine the available power based on a switching frequency of at least one of the one or more switches.

40. 30. The device of claim 27, wherein the power monitor circuitry is configured to determine the power consumption of the implantable device based on an operational mode of the implantable device.

41. The power consumption is consumed by a load circuit of the implantable device, and the power monitor circuit comprises: Detecting a current value of a current that drives the load circuit; determining the power consumption from the detected current value; 28. The device of claim 27, configured to:

42. 30. The device of claim 27, wherein the available power comprises a supply power provided by the electrical signal, the electrical signal producing a first voltage at a first voltage node, and the control circuitry configured to determine whether the supply power exceeds the power consumption.

43. 43. The device of claim 42, wherein the control circuitry is configured to control a power conveyor circuit to charge an energy storage device based on the first voltage node in response to determining that the supply power exceeds the power consumption, wherein charging the energy storage device reduces the first voltage.

44. 44. The device of claim 43, wherein the control circuitry is configured to determine whether the energy storage device is fully charged.

45. 45. The device of claim 44, wherein the control circuitry is configured to, in response to determining that the supply power exceeds the power consumption and that the energy storage device is fully charged, control the ultrasonic transducer to transmit the information to the interrogator including an indication that the implantable device is over-powered.

46. 46. ​​The device of claim 45, wherein the information including the instructions is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power less than the wave power of the powering ultrasonic wave.

47. The control circuit includes: determining whether the first voltage exceeds a predetermined voltage level; In response to determining that the first voltage exceeds the predetermined voltage level and the energy storage device is fully charged, open one or more switches configured to generate the electrical signal from the powering ultrasonic wave to reduce the supplied power.

45. The device of claim 44, configured to:

48. 44. The device of claim 43, wherein the control circuitry is configured, in response to determining that the supply power is less than the power consumption, to control the power conveyor circuitry to discharge the energy storage device through the first voltage node, wherein discharging the energy storage device increases the first voltage.

49. 43. The device of claim 42, wherein the control circuitry is configured to control the ultrasonic transducer to transmit the information to the interrogator including an indication that the implantable device is underpowered in response to determining that the supplied power is less than the consumed power.

50. 50. The device of claim 49, wherein the information including the instructions is configured to be receivable by the interrogator and causes the interrogator to generate a second powering ultrasonic wave having a second wave power greater than the wave power of the powering ultrasonic wave.

51. An interrogator device comprising: Transmitting a first power supply ultrasonic wave having a first wave power to an implantable device; receiving communication ultrasound from the implantable device, the communication ultrasound including information indicating whether more or less power should be transmitted to the implantable device; transmitting a second power supply ultrasonic wave having a second power based on the information to the implantable device; 16. An interrogator device comprising an ultrasonic transducer configured to:

52. Extracting the information from the communication ultrasonic waves; controlling the ultrasonic transducer to transmit the second power supply ultrasonic wave having the second power; 52. The device of claim 51, further comprising a controller configured to:

53. 53. The device of claim 51 or 52, wherein the second ultrasonic power supply comprises a pulse-width modulated (PWM) signal.

54. The device of claim 53, wherein the ultrasonic transducer is configured to control an instantaneous intensity value or a pulse width of the PWM signal based on the information to cause the second power supply ultrasonic wave to have the second wave power.